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ABSTRACT 
 
The work presented herein details post-translational modifications (PTMs) in Staphylococcus 
aureus that are involved in mediating the stress response and normal cellular processes. The first 
PTM that was investigated is regulated intramembrane proteolysis (RIP) for the activation of the 
ECF sigma factor σS. We achieved this by analyzing the role of the site-1 protease, which we 
termed “putative regulator of sigmaS” (PrsS), as it is predicted to be the first enzyme in the RIP 
cascade, leading to the activation of σS. It was determined that the putative site-1 protease, prsS, 
mimics transcriptional profiles of sigS; with expression low in all strains examined other than in 
the highly mutagenic strain RN4220. Moreover, up-regulation of the protease was observed in 
response to cell wall-targeting antibiotics, DNA-damaging agents, and during infection in human 
serum and RAW 264.7 cells, similar to that previously demonstrated for sigS. It was further 
determined that prsS mutants, like sigS mutants, are more sensitive to cell wall-targeting 
antibiotics and DNA-damaging agents, which is explained, in part, by alterations in altered 
abundance of proteins in the prsS mutant that mediate antibiotic resistance (Pbp2a, FemB, and 
HmrA) and the response to DNA damage (BmrA, Hpt, and Tag). Importantly, transcriptional 
analyses of proteins affected in the protease mutant, revealed that their expression is decreased in 
both prsS and sigS mutants, suggesting that this is a result of sigS-mediated regulation. Lastly, it 
was determined that PrsS, similar to σS, is required for infection in whole human blood and 
murine models of virulence. Next, since the abundance of a stress response protease, HtrA1, was 
altered in prsS mutants, we aimed to assess the roles of this enzyme, and its homolog HtrA2 in S. 
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aureus. Interestingly, we first determined that unlike that previously described for the HtrA 
enzymes, these proteases do not have a role in Agr-mediated virulence regulation. We attribute 
this finding to unintended mutations likely introduced during strain construction, which is 
common for S. aureus strains. We next used transcription profiling of the htrA genes in order to 
understand their role in the cell, and found that they are moderately expressed under standard 
conditions, and are up-regulated in response to both in vitro and ex vivo stressors that lead to cell 
protein, DNA, and cell envelope damage. Further to this, the protease mutants are more sensitive 
to numerous conditions that affect macromolecular stability, including elevated temperature, 
alterations in pH, reactive oxygen species, DNA damage, and antimicrobial stress. In order to 
further explore these sensitivities and gain insight into putative substrates, we employed a yeast-
2 hybrid screen, and identified numerous proteins that interact with HtrA1 and HtrA2, including 
those that mediate the response to stress and normal cellular homeostasis. Taken together, we 
provide evidence to suggest the HtrA proteases in S. aureus are required both during standard 
conditions and in stress-inducing environments to mediate protein folding and proteolysis of a 
broad range of substrates. Finally, we performed the first examination of prenylation in a 
bacterial organism. Prenylation is a well-studied post-translational modification (PTM) in 
eukaryotes, wherein a prenyl group is added to a metabolite or the C-terminal “CAAX” motif of 
a protein. Interestingly, the machinery exists for this PTM in a wide variety of prokaryotic 
species, thus we set out to investigate its impact in S. aureus. To achieve this, we disrupted 
prenyl group synthesis by inactivating ispA, the gene encoding a prenyl synthetase. The 
abrogation of prenylation ensued in striking alterations in the cell, including lack of pigmentation 
and smaller colony size, similar to small-colony variants (SCVs) of S. aureus. In addition to this, 
the ispA mutant displayed a growth defect, as a result of lower ATP levels. Moreover, the 
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prenylation mutant displayed alterations in resistance to antibiotics, including increased 
resistance to aminoglycosides and antimicrobial peptides (AMPs), yet elevated sensitivity to cell 
wall-targeting antibiotics. These differences in susceptibility to cell envelope targeting 
antibiotics are a result of alterations in cell envelope architecture, including variations in fatty 
acid composition and increased membrane fluidity. Collectively, the pleotropic consequences of 
the disruption of prenylation indicate that this process is key to maintaining cellular homeostasis 
in S. aureus, and perhaps other bacterial species. 
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CHAPTER 1: 
 
INTRODUCTION 
 
Staphylococcus aureus – the bacterium. S. aureus is a Gram-positive, non-spore forming, 
facultative anaerobe that can be found on people, animals, and in the environment. Its cells are 
approximately 0.5-1.0 µm in diameter, and grow in clusters, from which the term 
“Staphylocccus” is derived (1). The species name, “aureus”, describes the varying degree of 
golden pigmentation exhibited by isolates. S. aureus cells contains numerous genetic elements, 
including a lone circular chromosome of approximately 2.8 million base pairs, as well as 
numerous plasmids, bacteriophages, pathogenicity islands, transposons, and resistance islands (2, 
3). This genomic complexity allows the pathogen to be adaptable and thrive in the human host. 
To this latter end, S. aureus is, perhaps surprisingly, an unproblematic inhabitant of the nares of 
up to 50% of the human population (4). This colonization most commonly initiates via direct 
carriage or aerosolization of the bacterium into the nose, which provides a favorable niche for the 
bacterium to exist as a commensal organism (5-7). The seemingly benign carriage of S. aureus, 
however, has been correlated with auto-infection of patients who acquire an infection requiring 
antibiotic treatment (8-10). 
 
S. aureus – the pathogen. In addition to its lifestyle as a human commensal, S. aureus can also 
be harmful to its host. Indeed, hosts who are natural carriers of S. aureus are up to 6-times more 
likely to acquire an infection than non-carriers (11). As a pathogen, S. aureus is able to colonize 
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almost every part of the human body, causing diseases ranging from mild skin infections such as 
rashes, folliculitis, and boils to life-threatening conditions, such as toxic shock syndrome, 
pneumonia, bacteremia, necrotizing fasciitis, and endocarditis. In addition to these ailments, S. 
aureus is a leading cause of surgical and indwelling medical device infections, which lead to 
increased hospital stays and mortality (12-17). This ability of the organism to cause such a 
variety of diseases is a phenomenon not seen for most other infectious agents, which usually 
target the host in limited ways. As such, it is predicted that there are between 1,400,000-
3,500,000 cases of S. aureus bacteremia world-wide annually, with 10-30% of these resulting in 
death (18). Moreover, S. aureus leads to more annual deaths than HIV/AIDS in the United States 
(19-22). 
 
Multi-drug resistance of S. aureus. In addition to the multitude and severity of diseases it 
causes, S. aureus continues to remain a problem for medical professionals due to its ability to 
rapidly acquire resistance to available antibiotic treatments (23). The first documented case of 
resistance by S. aureus to an antibiotic occurred in 1943, which was within one year of the 
introduction of penicillin to the clinical setting (24). In efforts to combat this problem, 
methicillin, a synthetic penicillin derivative, was introduced in 1959. The chemical structure of 
methicillin is modified so that it circumvents β-lactamases, which render traditional β-lactam 
antibiotics inefficient. However, as seen with penicillin, resistance was acquired to methicillin 
one year after its use to treat patients (25). An additional drug, the glycopeptide antibiotic 
vancomycin, which was isolated prior to methicillin, was thought to be promising as resistance 
was not acquired for decades after its introduction. The mechanism of action differs from β-
lactam antibiotics in the ability of vancomycin to disrupt both synthesis and incorporation of 
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peptidoglycan subunits in the cell wall, and influence cell membrane stability (26). However, the 
first indication of evolving resistance to this agent was documented in 1996, when patients 
infected with vancomycin-intermediate S. aureus (VISA) required higher-than-standard dosages 
for effective treatment (27). The prevalence and subsequent increase in VISA cases was 
attributed to mutations of several genes including walkR, graRS, vraSR, yvqF, and rpoB that 
resulted in increased cell wall thickness, inhibiting the uptake of vancomycin by the pathogen 
(28). Six years after the appearance of VISA, complete resistance was observed in the form of 
vancomycin-resistant S. aureus (VRSA) (29). This resistance was a result of the conjugative 
transfer of Tn1546 containing the vancomycin resistance gene vanA from vancomycin-resistant 
Enterococcocus faecalis (30, 31). 
 
In order to combat emerging drug-resistance of S. aureus, novel classes of antibiotics have been 
approved for use in patients including cephalosporins, oxazolidinones, and lipoglycopeptides. 
The cephalosporin ceftaroline, which was approved in 2010 by the United States Food and Drug 
Administration (10), is used to treat VRSA skin and pneumonia infections (32). Although 
ceftaroline is a β-lactam antibiotic, it is able to bind penicillin-binding protein 2a (Pbp2a), in 
addition to the other penicillin-binding proteins (Pbps) responsible for earlier generation β-
lactam resistance, in order to inhibit bacterial cell wall synthesis (33). More recently, an 
additional cephalosporin, ceftobiprole, which has high affinity for Pbps, has recently been 
approved for treatment of VRSA pneumonia infections (34). In addition to this a new 
oxazolidinone, tedizolid, has shown efficacy against MRSA infections which are resistant to the 
first used oxazolidinone, linezolid (35). Tedizolid contains a modified D-ring, which allows it to 
more efficiently bind the 50S ribosomal subunit, thus inhibiting bacterial protein synthesis (36). 
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Lastly, three new lipoglycopeptide antibiotics have shown activity against VISA (telavancin and 
dalbavancin) and VRSA (oritavancin) skin and skin structure infections (SSSIs) (37). Although 
these antibiotics have made recent advancements in the treatment of certain MRSA and VRSA 
infections, the need for new antibiotics is persistent as resistance is rapidly acquired by S. aureus 
strains. 
 
Emergence of community-associated methicillin resistant S. aureus (CA-MRSA). The 
alarming manner in which S. aureus is able to evade new antimicrobial therapies is compounded 
by the ability of the pathogen to readily infect the human host. Historically, those who acquired 
S. aureus infections were immunocompromised or in contact with healthcare facilities, 
personnel, or patients. These infections were caused by hospital-associated methicillin-resistant 
Staphylococcus aureus (HA-MRSA), which was first documented in the 1960s, but continues to 
be a major concern in the medical field today (20). In the last decade, however, an increase in S. 
aureus infections of healthy individuals with no history of a MRSA infection, and no association 
with healthcare facilities, personnel, or patients, was observed (38, 39). These infections are 
caused by CA-MRSA, which infect people in close contact with one another, such as those in the 
military, sports teams, schools, daycare facilities, and prisons (40-43). The first documented case 
of CA-MRSA in the US occurred in the late 1980s at The University of Chicago Children’s 
Hospital where 1 out of 8 children with a CA-MRSA infection had no pre-disposing risks (44). 
Following this, a study in the 1990s found that 20 out of 25 patients in a western Australian 
hospital were infected with MRSA clones endemic to northern Australia (39). Currently, CA-
MRSA infections have been documented in every continent apart from Antarctica (45). 
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HA-MRSA differs from CA-MRSA in several ways, as HA-MRSA infections are typically 
chronic and more drug-resistant than CA-MRSA. The two also exhibit genetic variation, as CA-
MRSA contains SCCmec types IV, V, or VII and commonly possess the Panton-Valentine 
leukocidin (PVL) toxin, whereas HA-MRSA contains SCCmec types I, II, III, and VI and lack 
the PVL toxin (46-52). The most prevalent reported CA-MRSA clone in the US is sequence type 
ST8-IV (USA300) (53). This S. aureus clone encodes an arginine catabolic mobile element 
(ACME), not found in other CA-MRSA strains, which is hypothesized to be acquired by 
horizontal gene transfer from Staphylococcus epidermidis, and is attributed to increased 
pathogenesis of USA300 compared with other sequence types (54). Specifically, ACME contains 
multiple elements which enhance survival of the pathogen on and in human skin including the 
arginine-deiminase system (Arc) that promotes survival in the acidic environment, and SpeG that 
is required for resistance against polyamines produced by the skin (55). Apart from the increased 
survival advantage provided by ACME, elevated pathogenesis can also be attributed in part to 
the increase in virulence factor production including α-toxin and α-type phenol soluble modulins 
(PSMs) (56). Despite the fact that HA-MRSA strains are more drug-resistant and maintain a 
strong presence in hospitals, it has been suggested that CA-MRSA are displacing HA-MRSA in 
clinical settings (57). 
 
Virulence factors of S. aureus. S. aureus has numerous virulence determinants that allow it to 
cause massive damage to its host. These virulence factors include those that are expressed on its 
cell wall, and collectively allow for the initial attachment to host cell tissues, entrance into host 
cells, and evasion of the immune system so that infection may proceed (58). These cell surface-
associated proteins are anchored to the cell wall by Sortase A-mediated processing (59). 
6 
 
Specifically, proteins containing C-terminal “LPXTG” are cleaved between threonine and 
glycine in the motif by Sortase A, and attached to lipid II. This processed protein is then 
anchored into the surface of the cell during cell wall synthesis (60). The most numerate type of 
cell wall virulence factors are the microbial surface components recognizing adhesive matrix 
molecules (MSCRAMMs), which characteristically contain multiple N-terminal IgG-binding 
domains that promote initial attachment to host cells (61, 62). Studies performed on the 
numerous MSCRAMMs reveal the necessity of these proteins in the infection of a variety of host 
cells. Specifically, the colonization of human can be attributed by the attachment of clumping 
factor B (ClfB) to protein loricrin of squamous epithelial cells in human nares (63-68). This cell 
wall protein, along with clumping factor A (ClfA), has also been demonstrated to facilitate 
progression of infection through the bloodstream, into bones, and in organs such as the heart and 
kidneys (69-71).  An additional set of MSCRAMMs, the fibronectin-binding proteins (FnBPs) 
are capable of binding arterial cells of the heart and epithelial cells of mammary glands (72).  In 
addition to the numerous MSCRAMMs, surface protein A was originally identified by its 
abundant presence and ability to elicit an immunogenic response in rabbit models (73). This 
ubiquitous protein, which is both anchored to the cell wall and released into the extracellular 
milieu, contains five Ig-binding domains which allows for host immune system activation (74-
76). An additional family of cell wall-associated proteins, the near iron transport (NEAT) motif-
containing proteins, facilitate iron-binding within the host environment (77). This process of iron 
acquisition is achieved via the iron-regulated surface determinant (Isd) system, comprised of four 
cell wall-associated proteins: IsdA, IsdB, IsdC, and IsdH (78, 79). IsdA, IsdB, and IsdH are 
hemoprotein receptors, capable of binding hemoglobin and haptoglobin-hemoglobin (78), and 
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IsdC facilitates transport of heme received from IsdA through the cell wall into the cytoplasm 
(80, 81). 
 
Once an infection has been established, S. aureus produces extracellular virulence factors 
including toxins and proteases. The pathogen contains several pore–forming toxins including α-
hemolysin, γ-hemolysin, leukocidins, and PVL (82). Specifically, α-hemolysin binds to host cells 
containing the ADAM10 receptor, and initiates heptameric pore formation, which triggers 
activation of the immune system or host cell lysis in a toxin dependent manner (83, 84). Unlike 
α-hemolysin, γ-hemolysin, leukocidin AB, leukocidin ED, and PVL are heteromeric, requiring 
two subunits, F and S class components, to form a barrel in host cell membranes (85-90). An 
additional group of cytolytic toxins are peptides termed “phenol-soluble modulins” (PSMs) that 
are classified into α and β types depending on their length (91). At approximately 20 amino acids 
in length, the α-types, PSMα1-4 and δ-toxin, are half the size of β-types PSM β1-2. These small 
peptides are capable of lysing human neutrophils, leukocytes, osteoblasts, and monocytes (92). 
This destruction of cells can be mediated extracellularly in a concentration dependent manner, 
whereby at low concentrations of the PSM, the toxin binds to host receptors and stimulates a 
proinflammatory response, and at high levels of the PSM, the toxin inserts into the host cell 
membrane, resulting in cell lysis (93). Alternatively, host destruction may occur from within the 
cell when lysis is induced by PSMs after S. aureus phagocytosis (94). The impact of PSMs on 
virulence was elucidated in both murine abscess and sepsis models of infection, wherein mutants 
of PSMα1-4 or δ-toxin caused less virulence compared to wild-type strains (91). Another set of 
toxins, staphylococcal enterotoxins (SEs) and toxic shock syndrome toxin-1 (TSST-1), are 
collectively referred to as “superantigens” because of the ability of the enzymes to elicit a 
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massive T cell immune response (95). The SEs most commonly lead to food-poisoning illnesses, 
while TSST-1 causes toxic shock syndrome, resulting in organ failure and shock (96, 97). 
Further to these, the exfoliative toxins A and B are serine proteases which cause damage to the 
host by cleaving host epidermal cell desmoglein-1, disrupting normal skin architecture, leading 
to scalded skin syndrome (98-100). S. aureus also secretes other proteases, such as aureolysin, 
the V8 protease (SspA), staphopains A and B (ScpA and SspB), and the less well studied Spl 
proteases, each of which have been implicated in the transition from biofilm to planktonic 
growth (101-103). In addition to this, a study performed on a mutant lacking all ten secreted 
proteases (aureolysin, SspA, SspB, ScpB, and SplABCDEF) revealed a role of the proteases in 
the regulation of other virulence determinants. Specifically, there was an increase in numerous 
toxins and surface proteins in the protease-null strain that resulted in hyper-virulence of the strain 
in a murine model of sepsis (104). Finally, host-specific substrates have also been identified for 
some of these proteases. Specifically, aureolysin cleaves the human antimicrobial peptide LL-37, 
complement protein C3, and plasminogen, and the staphopains degrade host fibrinogen and 
collagen (105-108).   
 
Regulation of virulence factors. The highly-coordinated regulation of cell-associated and 
secreted virulence determinants is necessary for establishing and maintaining infection. As 
virulence mechanisms are not required for the cell at all times, as is the case during colonization, 
they are not constitutively expressed. Instead, they are controlled by several classes of regulators, 
including two-component regulators, regulatory RNAs, DNA-binding proteins, and alternative 
sigma factors. S. aureus encodes 16 two-component regulators which function to control 
numerous cellular processes and virulence (109). One of these two-component systems, AgrCA, 
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mediates the signal transduction of the Agr global regulatory system (110). The agr locus is 
composed of an RNAII transcript expressed from promoter P2, and encodes AgrBDCA. 
Divergent to this is the RNAIII transcript expressed from promoter P3, which functions as a 
regulatory RNA, and also encodes δ-hemolysin. The remaining proteins encoded on this operon, 
AgrD and AgrB, form the auto-inducing peptide (AIP), whereby AgrD is processed by protease 
AgrB to form the thiolactone octapeptide (111).  
 
Maximal expression of the Agr system occurs during post-exponential growth in vitro and upon 
high accumulation of bacterial loads in vivo (110, 112). Activation of the system is achieved 
when the sensor histidine kinase AgrC senses an extracellular accumulation of AIP, and 
phosphorylates the response regulator AgrA, which then up-regulates transcription from both P2 
and P3 promoters (113). This results in increased expression of the Agr proteins, RNAIII, and δ-
hemolysin. RNAIII is a regulatory RNA that complementarily pairs with rot mRNA, which 
encodes the transcriptional regulator Rot (Repressor of Toxins), as well as the mRNA of certain 
virulence factors (114, 115). The binding of RNAIII to rot mRNA blocks production of Rot, 
resulting in de-repression of secreted virulence factor expression and repression of cell surface 
protein transcription (116, 117).  
 
Transcriptional regulation of this global regulatory system is required to ensure appropriate 
temporal expression. This regulation is mediated in part by SarA, a member of the Sar family of 
winged-helix-motif-containing proteins that bind DNA in order to regulate gene transcription 
(118).  SarA positively regulates the Agr system by binding promoter regions of P2 and P3, 
resulting in increased expression of RNAII-encoded Agr proteins, RNAIII, and δ-hemolysin 
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(119-121). In addition to regulating Agr, SarA functions alongside Agr to positively regulate the 
expression of the SaeRS two component regulator, which is considered an additional global 
regulator of gene expression (122, 123). The histidine sensor kinase SaeS is activated in response 
to various membrane stressors, including hydrogen peroxide and α-defensins, and 
phosphorylates the response regulator SaeR, resulting in the transcription of numerous genes 
(124). These positively regulated genes include a multitude of virulence factors, including 
extracellular proteases such as nuclease (Nuc), host cell adhesion and immune evasion proteins, 
and leuokocidins (125).  
 
Sigma factor-mediated transcriptional regulation. An additional mode of genetic regulation is 
mediated by sigma factors, in which the initiation of gene transcription is facilitated by the 
association of the transcription factor with core-RNA polymerase to allow for promoter 
recognition. Sigma factors are classified into two families: σ70 which are found in all bacteria, 
and σ54, rare sigma factors required for nitrogen metabolism (126). The σ70 family can be further 
classified into four groups, including group 1 (housekeeping), group 2, group 3, and group 4, 
differentiated by structural composition and varying number of DNA-binding domains. 
Housekeeping sigma factors, which mediate transcription of thousands of genes required for 
normal cellular processes, contain 4 domains (127). These domains, σ1.1, σ2, σ3, and σ4, are 
assembled together by flexible linkers that allow for plasticity required for the protein to interact 
with RNA polymerase and DNA promoter regions. Specifically, the interaction between RNA 
polymerase and a sigma factor is intricately coordinated, whereby a transient interaction is 
initiated by the binding of region 2 of a sigma factor to the β’ subunit of core RNA polymerase, 
forming the RNA polymerase holoenzyme (128). This binding of the sigma factor must occur for 
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recognition of the promoters, as unbound sigma factor proteins remain in a conformation in 
which its domains cannot recognize promoter regions (129). Subsequent to the association of the 
transcription factors, the RNA polymerase holoenzyme binds to -35 (TTGACA) and -10 
(TATAAT) promoter regions of target DNA, via domains σ4 and σ2 of the sigma factor, 
respectively (130). Transcription begins with the formation of a transcriptional bubble that is 
mediated by the flipping of the -11 nucleotide (A) by the σ2 domain (131). Once a nascent 
transcript reaches approximately 15 to 16 nucleotides, its interaction with RNA polymerase 
forces the dissociation of the sigma factor from the holoenzyme (132), freeing the sigma factor to 
be recycled and facilitate transcription from other promoter sequences. 
 
The role of extracytoplasmic function (ECF) sigma factors. In addition to essential 
housekeeping sigma factors, bacteria also possess alternative sigma factors, which mediate the 
transcription of genes required to overcome stress. The most numerate of these alternative sigma 
factors are the ECF sigma factors, which comprise group 4 of the σ70 family (133-136). 
Transcription mediated by these sigma factors occurs by a similar mechanism to that of 
housekeeping genes, with differences resulting from the structural composition of ECF sigma 
factors, and the promoters they recognize. From a composition perspective, ECF sigma factors 
lack regions σ1.1 and σ3, and consist solely of σ2 and σ4 domains, hindering the ability of the 
sigma factor to recognize housekeeping promoters (137, 138). Indeed, ECF sigma factors 
recognize different promoter regions than housekeeping sigma factors, composed of different -10 
and -35 (-35 usually contains “AAC”) motifs and length of the spacer region, which are specific 
for alternative sigma factor recognition (134). This recognition of these alternative promoter 
consensus sequences results in transcription of genes required to mediate the response to a 
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variety of environmental stressors including alterations in temperature, pH, osmolarity, oxidative 
stress, metal stress, or the presence of antibiotics (134, 139-144).  
 
The most well characterized ECF sigma factors are those that are homologous to σE from E. coli. 
σE was first purified and identified from E. coli cells exposed to heat shock of 50 °C (145). Upon 
exposure to this high temperature, σE mediates transcription of heat shock genes from the P3 
promoter of rpoH, encoding σ32, required for the expression of heat shock genes. The presence of 
σE in over 100 bacterial species underscores its requirement for heat stress response (146). 
Indeed, the sigma factor mediates transcription of numerous chaperones and proteases involved 
in the repair or degradation of misfolded proteins, a hallmark consequence of increased 
environmental temperature (147).  Additionally, σE has been shown to be required for virulence 
in numerous pathogens, including Salmonella enterica, in which mutants lacking the sigma 
factor are unable to express SsrB-regulated virulence genes involved in type-III secretion at 
wild-type levels, and are also unable to express the outer-membrane lipoprotein SmpA that is 
required for systemic infection in murine models (148, 149). 
 
Significant advances and changes in paradigms have been made since the initial discovery of 
ECF sigma factors. One of the initial classifications of ECF sigma factors was that they are co-
transcribed with a downstream cognate anti-sigma factor (150). Moreover, the anti-sigma factor 
was also membrane-bound, and formed an association with the sigma factor at the membrane-
cytoplasm interface, that required proteolysis for activation. Although these hallmarks of ECF 
sigma factors are in line with many of ECF sigma factors that have been studied, there now exist 
exceptions to these ideas. For example, some ECF sigma factors are regulated by soluble anti-
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sigma factors, as is the case for oxidative stress response mediator σR in Streptomyces coelicolor 
and σE in Rhodobacter sphaeroides (151, 152). Activation of these sigma factors occurs by a 
conformational change in the anti-sigma factor, allowing for the release of the sigma factor. 
Moreover, some sigma factors lack a cognate anti-sigma factor altogether, and rely on different 
mechanisms of activation. For example, the HrpL sigma factor in Pantoea stewartii is activated 
by the HrpXY two-component system, which responds to oxidative stress, activating 
transcriptional activator HrpS, which in turn upregulates the hrp regulon (153). 
 
Regulation of ECF sigma factors by regulated intramembrane proteolysis (RIP). In order to 
mediate transcription of genes required to combat a variety of extracellular stressors, most ECF 
sigma factors are activated by regulated intramembrane proteolysis (RIP) (154, 155). This 
process, which is required in order to release a tethered sigma factor from its cognate anti-sigma 
factor, is initiated by the sensing of a stress stimulus. Following this, the sequential cleavage of 
the anti-sigma factor is mediated by membrane-embedded site-1 and site-2 proteases, and then 
additional processing by intracellular proteases (Figure 1) (156). This process is well 
characterized for σE in E. coli that responds to heat shock. Activation of this sigma factor is 
initiated in response to an increase in abundance of outer membrane proteins and the presence of 
misfolded proteins in the periplasm (157, 158). This response is sensed by RseB, which under 
non-stress conditions binds the periplasmic domain of the anti-sigma factor, RseA (159). Upon 
sensing misfolded proteins, RseB dissociates from the anti-sigma factor, and σE is released from 
the cytoplasmic domain of RseA via cleavage by the site-1 and site-2 proteases, DegS and RseP, 
respectively (160-162). This allows σE to modulate the transcription of over 40 genes necessary 
for repairing or degrading misfolded proteins and cell envelope components (163). 
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RIP has also been studied in B. subtilis, which encodes seven ECF sigma factors (164). Of these 
alternative sigma factors, σW, is activated when the cell is exposed to stressors that result in cell 
wall damage, including antimicrobial peptides or alkaline shock (165, 166). RIP begins when σW 
is released from its cognate anti-sigma factor, RsiW, via cleavage by the site-1 protease PrsW 
(167, 168). This protease was discovered by Ellermeier and colleagues during an investigation of 
cannibalism, in which B. subtilis cells resist becoming spores by killing neighboring cells in 
order to uptake nutrients. This antibiosis is achieved by production of the SdpC toxin by 
sporulating cells, which also produce the SdpI immunity protein in order to avoid self-
destruction (169). Interestingly, it was found that cells lacking the SdpI immunity protein contain 
a gain-of-function mutation in prsW, leading to SdpC toxin resistance. This gain-of-function 
mutation leads to activation of σW by constitutive site-1 proteolysis by PrsW, followed by site-2 
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proteolysis by RasP (170). As such, cell survival is achieved by σW-mediated transcription of 
genes that compensate for a lack of SdpI. The activation of σW under stress conditions leads to 
transcription of at least 89 genes, including sigW, rsiW, and genes involved in the stress response 
to the SpdC toxin, antibiotics, altered temperature, and ethanol (171, 172). 
 
More recently, RIP has been demonstrated for activation of σV of B. subtilis (173). Increased 
cleavage of the anti-sigma factor, RsiV, occurs in a dose dependent manner in response to 
increasing concentrations of lysozyme. Although this activation is similar to that of σW, the 
initiation of the proteolytic cascade is independent of PrsW, as RsiV cleavage occurs in prsW 
mutants. However, proteolysis of the sigma factor is dependent on the site-2 protease, RasP, as 
cleavage does not occur in rasP mutants. Therefore, the proposed model for σV activation is that 
a yet undiscovered site-1 protease initiates cleavage of RsiV, followed by RasP-mediated site-2 
cleavage, thereby releasing the sigma factor for transcription of genes required for survival to 
cell envelope stress. 
 
The regulation of ECF sigma factors and cognate anti-sigma factors, CsfT-RsiT, CsfU-RsiU, and 
CsfV-RsiV, in Clostridium difficile has also been elucidated (174). Expression of csfT and csfU 
is increased in response to sub-inhibitory concentrations of bacitracin or lysozyme; whilst csfV 
transcription is increased by lysozyme, yet unaffected by bacitracin. Additionally, expression of 
the two sigma factors (CsfT and CsfU), which are upregulated by both antibiotics, is down-
regulated in prsW mutant strains, suggesting a requirement for the protease to activate these 
sigma factors. Moreover, it was determined that the decrease in expression of CsfU is likely 
mediated at the post-translational level, as proteolysis of RsiU does not occur in a prsW mutant. 
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Finally, the inhibition of RIP in prsW mutants also leads to increased sensitivity of strains to 
bacitracin and lysozyme, and decreased virulence in hamster models of infection. 
 
Alternative sigma factors of S. aureus. S. aureus encodes three alternative sigma factors: σB, 
σH, and σS (175-177). The most studied of the three transcription factors is σB, which is induced 
in response to heat and alkaline stress, mediates resistance to antibiotics, and promotes increased 
transcription of adhesins in infection models  (178-181). Less is known about σH, which has been 
shown to be involved in competence and prophage integration and excision (176, 182). Lastly, 
σS, a member of the ECF sigma factor family, was discovered in our laboratory, and is involved 
in the response to a variety of intracellular and extracellular stressors (175, 183). Specifically, 
sigS mutants show drastically reduced ability to withstand cell envelope stress when challenged 
with cell wall antibiotics ampicillin, bacitracin, and penicillin-G. Additionally, sigS mutants are 
more sensitive to DNA-damaging stress induced by methyl methanesulfonate (MMS), sodium 
hydroxide, and hydrogen peroxide. Moreover, these same challenges that are encountered during 
infection render the sigma factors mutants more susceptible to killing by whole human blood and 
murine macrophage-like cells (RAW 264.7). The requirement for σS in cellular protection during 
infection was demonstrated in a murine model of septic arthritis in which mice infected with the 
mutant strain exhibited decreased morbidity and mortality (175). 
 
High temperature requirement A (HtrA) proteases. Additional proteases implicated in the 
stress response of prokaryotes are the HtrA enzymes. These “housekeeping” enzymes are 
conserved amongst both prokaryotes and eukaryotes as they are involved in the essential process 
of protein quality control (184-186). These enzymes eliminate the presence of misfolded proteins 
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in the cell either by ATP-independent proteolysis or substrate refolding, which is why they are 
commonly referred to as “protease-chaperones” (187). HtrAs belong to the S1 family of 
peptidases, which characteristically contain a signal peptide or transmembrane domain, trypsin-
like proteolytic domain containing a catalytic triad composed of a histidine, aspartic acid, and 
serine residue, and at least one PDZ domain (Figure 2) (188). The conserved histidine and serine 
residues were shown to be essential for catalytic function in E. coli, whereby single site directed 
mutagenesis in either of the two residues inhibited HtrA from degrading purified β-casein or 
resorufin-labeled β-casein; and prevented auto-cleavage observed during wild-type HtrA 
purification (189). Furthermore, HtrA catalytic site mutants were also unable to provide 
protection against heat at 44 °C, indicating that proteolytic activity is necessary for cell survival 
at increased temperature. Lastly, these catalytic residues do not appear to be responsible for 
maintaining secondary structure, as mutations of the histidine or serine residues did not affect 
protein conformation. 
 
In addition to the conserved proteolytic domain, HtrA proteases characteristically contain at least 
one PDZ domain, necessary for substrate binding, at their C-terminus (190). The HtrA (DegP) of 
E. coli contains two PDZ domains, designated PDZ1 and PDZ2, which are necessary for 
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performing two different roles (191). Specifically, PDZ1 is required for proteolysis, as proteins 
lacking this domain are unable to degrade malate dehydrogenase (MDH), β-casein, or lysozyme. 
In addition to this, PDZ1 is also involved in C-terminal peptide recognition and sequestration, as 
mutants lacking the domain are unable to properly fold enhanced green fluorescent protein 
(EGFP)-tagged peptides in fluorescence binding assays.  The PDZ2 domain is involved in 
maintaining structural integrity of the protease complex, as mutations in PDZ2 inhibited HtrA 
from assembling into a hexameric cage. Interestingly, single or double deletions of these 
domains does not affect the ability of the protease to fold unfolded citrate synthase, indicating 
that neither PDZ domain is required for chaperone activity of the protease. 
 
The crystal structure of HtrA in E. coli was solved in order to predict protein-protein interactions 
(192), validating previous hypotheses that the protein is organized into three domains: a protease 
domain and two PDZ domains (PDZ1 and PDZ2). In E. coli, these domains constitute the 
monomers that result in functional hexamers in necessary to form a cage around proteins to be 
processed. This size of the HtrA cage is dependent on the organism, and these structures, which 
are assembled as multiples of 3, have been reported to be as large as 30-mer complexes (185). 
The assembly of cage complexes is a dissociable process in which cage formation facilitates the 
proteolytic role of HtrAs. Subsequent to cage formation, PDZ1 and PDZ2 coordinate the 
initiation of peptide processing, wherein PDZ1 allows for entrance and binding of unfolded or 
mis-folded peptides, and PDZ2 is required for peptide anchoring. After entering the cage formed 
by the PDZ domains, proteins may be properly folded or degraded, depending on the 
conformation of loop-forming amino acid motifs LA, L1, and L2 of the protease domain. 
Thermally favorable conditions render the LA, L1, and L2 loops in a conformation that blocks 
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access of proteins to the catalytic triad, resulting in inhibition of proteolysis. It is hypothesized 
that under increased temperature, the loops change conformation, allowing access to the catalytic 
site, and therefore, degradation of peptides that interact with the site. 
 
Functionally, HtrA proteases are required to combat heat stress, as well as a variety of other 
environmental stresses. HtrA was discovered in an E. coli transposon screen where an htrA 
mutant was unable to grow at temperatures above 44 °C (193). In addition to the observed 
sensitivity to elevated temperatures, E. coli htrA mutants are more susceptible to oxidative stress 
mediated by ferrous ions and cumene hydroperoxide (194). Similar deleterious effects from the 
lack of HtrA are observed in Gram-positive organisms. For example, initial investigations of one 
of the members of the HtrA family of proteases of B. subtilis (YkdA, YvtA, and YyxA) revealed 
that ykdA mutants are more resistant to exposure to temperature of 54 °C or hydrogen peroxide, 
leading the hypothesis that the remaining two proteases over-compensate for the loss of YkdA 
(195). This hypothesis was supported by subsequent studies in which single mutants of either 
ykdA or yvtA were more sensitive than wild-type strains to elevated temperature or hydrogen 
peroxide stress, yet double mutants of the proteases displayed decreased sensitivity to both 
stressors (196). In another Bacillus species, B. anthracis, htrA mutants are incapable of growth at 
42 °C, and grow poorly in the presence of ethanol, hydrogen peroxide, or NaCl (197). 
Additionally, it has been demonstrated that although B. anthracis encodes two HtrA proteases, 
HtrA and HtrB, transcription of htrB is significantly lower than htrA, and levels of HtrB protein 
are essentially undetectable. Therefore, in this organism, htrA and htrB do not appear to exhibit 
functional redundancies, and all phenotypes observed can be attributed solely to the loss of htrA. 
In Streptococcus mutans, HtrA is required for survival under high temperatures, hydrogen 
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peroxide-specific oxidative stress, mild acidic stress,  high salt stress, and survival in the 
presence of antibiotics, which induce protein instability (puromycin) and DNA-damage 
(mitomycin C) (198). HtrA in Lactococcus lactis is required for responding to increased 
temperatures and osmolarity, and exposure to ethanol and puromycin.  Interestingly, unlike that 
commonly found for htrA mutants, L. lactis mutants of this enzyme are not more sensitive to 
alteration in pH or oxidative stress (199).  
 
Mutations of HtrA proteases have also been shown to affect virulence in both Gram-positive and 
Gram-negative pathogens. For Gram-positives, most work on the role of HtrA proteases in 
virulence has been performed in Streptococcal species. Specifically, the importance of 
proteolytic activity of HtrA in Streptococcus pyogenes for virulence has been demonstrated 
(200). HtrA mutants of S. pyogenes are unable to process the SpeB zymogen, and exhibit 
increased hemolytic activity from hemolysin streptolysin S (SLS), suggesting a role for HtrA in 
the maturation of these virulence factors. Interestingly, this observed decrease in functionality of 
one virulence factor, SpeB, but increase in activity of another, SLS, means that htrA mutants 
remain virulent in murine models of subcutaneous infection. A study on protein secretion in htrA 
null-strains was also performed in Streptococcus mutans, in which it was found that mutants had 
impaired export of several factors implicated in pathogenesis, including glucan-binding proteins 
(GbpB, GtfB, and FTF), GAPDH, and enolase (198). Conversely, in Clostridium difficile 
hamster models of infection, htrA mutant strains exhibit increased virulence compared to the 
wild-type strain (201). This phenotype has been attributed to alterations in transcription of 
hundreds of genes, leading to increased levels of TcdA and Toxin A and Toxin B, in htrA 
mutants. The authors speculate that the abundant changes in the expression profile of htrA 
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mutants suggest that the protease may also function as a global transcriptional regulator.  
Alterations in virulence determinants production is also found in the highly-virulent Bacillus 
anthracis Vollum strain, wherein htrA mutants are unable to produce S-layer proteins Sap and 
EA1, and neutral protease A (NprA) (197). This striking alteration in protein profile may explain 
why in both guinea pig models of subcutaneous and intra-nasal infection, htrA mutants display 
decreased virulence.  
 
HtrA proteases of S. aureus. S. aureus encodes two HtrA proteases, HtrA1 and HtrA2, located 
750 genes apart on the chromosome.  In a previously performed study, htrA mutants displayed 
impaired growth at elevated temperatures in the COL background and sensitivity to puromycin 
stress in the RN6390 background (202). In this same study, the absence of δ–hemolysis and 
RNAIII transcript in the htrA1 htrA2 double mutant led the authors to suggest that HtrA1 and 
HtrA2 control Agr-mediated virulence by affecting secretion of virulence proteins. This was 
determined to be strain specific, however, as the virulence phenotype was observed only in 
RN6390 and not in COL. In an additional study investigating the functionality of S. aureus HtrA 
proteases, the two enzymes were expressed in an HtrA-deficient Lactococcus lactis strain (203). 
From this study, it was determined that heat resistance could be restored by complementation 
with HtrA1, but not by HtrA2. Additionally, the proteolytic ability of the two enzymes in L. 
lactis was measured by analyzing degradation products of an export fusion protein (Exp5-
ΔSPNuc), S. hyicus lipase (Lip), L. lactis autolysin (AcmA), and S. aureus nuclease (Nuc). The 
results from this experiment revealed that HtrA1, but not HtrA2, was able to degrade all four 
protein substrates. Taken together, these results suggest differing roles for the two proteases, or 
the requirement of S. aureus specific activators for HtrA2 function.  
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Additional prokaryotic post-translational modifications (PTMs). Post-translational 
modifications allow for the activation, inactivation, or expansion of function of a single protein. 
Proteolysis is the most common PTM, which is involved in numerous cellular processes 
including the activation of proteins (e.g. regulated membrane proteolysis) and the degradation of 
misfolded or damaged proteins (e.g. protein quality control) (155). In addition to proteolysis, 
PTMs include processes such as phosphorylation, which is the addition of a phosphate to an 
amino acid; commonly serine, threonine, tyrosine, histidine, aspartate, or arginine (204-207). In 
bacteria, phosphorylation is best understood in the context of two component regulators. In these 
systems, upon sensing of a signal, a sensor kinase becomes autophosphorylated at a conserved 
histidine residue (208). Subsequent to this, the sensor protein transfers the phosphate group to a 
cognate response regulator, which then coordinates gene expression (209).  
 
Another common PTM in bacteria is acetylation, or the attachment of acetyl groups to amine 
groups of lysine amino acids or the N-terminal amino acid. Acetylation of lysine mediates 
protein involvement in a variety of cellular processes, including the response to environmental 
stressors. This has been demonstrated in E. coli whereby a mutation of acetyltransferase YfiQ, 
resulting in a decrease in acetylated proteins, renders the bacteria more sensitive to heat and 
oxidative stress (210).  The second form of acetylation, which occurs at the N-terminus of 
proteins, is a less common occurrence. N-acetylation is observed for the ESAT-6 virulence factor 
of M. tuberculosis, and reduces binding affinity for chaperone CFP10 (211, 212). Additionally, 
N-acetylation of lipoproteins occurs in Gram-positive bacteria and has been found to induce the 
host immune response (213).  
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An additional PTM that has been well studied is methylation, wherein a methyl group is attached 
at a terminal amine of a lysine, arginine, or gutamine residue (N-methylation) or to the carboxyl 
end of a glutamic acid residue (O-methylation) (214). N-methylation has been recently been 
studied in Rickettsial species wherein methylation of OmpB is implicated in attachment and 
invasion of the host (215). O-methylation has been discovered to be involved in chemotaxis 
whereby methyl-accepting chemotaxis proteins (MCPs) in E. coli and B. subtilis allow for the 
movement of towards attractants (216-218).  
 
A less common modification, glycosylation, is the attachment of glycan subunits to asparagine, 
serine, or threonine amino acid residues (219). Similar to methylation, glycosylation occurs at 
amino (N) and carboxyl (O) termini of amino acid residues. This modification, which was 
previously thought to occur exclusively in eukaryotes, has recently been characterized in 
prokaryotes, with the majority of glycoproteins belonging to Gram-negative pathogens (220). In 
E. coli, TibA and AIDA-I are glycosylated proteins which contribute to host attachment and 
invasion of host cells (221, 222). Additionally, the pili of Neisseria and Pseudomonas, which are 
also important for host infection, species are also glycosylated (223-226). 
 
Finally, lipidation is the attachment of hydrocarbon chains to proteins, which occurs through a 
series of steps. This modification begins with the attachment of a diacylglycerol subunit to a 
cysteine residue at the end of a “lipobox motif”, followed by protein cleavage and acylation of 
the N-terminus (227). The resulting lipoprotein may then be translocated to the membrane, such 
as with the substrate binding proteins of ABC transporters (228). Alternatively, lipidated proteins 
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can be secreted from the cell by Sec, such as cell envelope lipoproteins Msmeg1712 and 
Msmeg1704 in M. smegmatis, or by Tat transport systems, as is the case for mycobacterial 
multicopper oxidase MmcO in M. tuberculosis (229, 230). 
 
Mechanism of protein prenylation as a PTM in eukaryotes. Prenylation is another type of 
post-translational modification, which has been well studied in eukaryotes, although little is 
known about this process in prokaryotes. In eukaryotes, this PTM occurs via a series of steps 
which facilitate the formation of a protein containing a prenyl group (Figure 3). These prenyl 
groups are either farnesyl (15-carbon moiety) or geranylgeranyl (20-carbon moiety), and are 
synthesized by farnesyl diphosphate synthase (IspA) (231, 232). The synthesized prenyl groups 
are attached by a farnesyl transferase or geranylgeranyl transferase (type-I) to the cysteine 
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residue of a C-terminal “CAAX” motif where “C” is cysteine, “A” is any aliphatic amino acid, 
and “X” is any amino acid, by a thioether bond (233).  Although the “CAAX” motif is the most 
common motif for prenylation in eukaryotes, type-II geranyltransferases can attach 
geranylgeranyl groups to “CXC” and “CCXX” motifs located near the C-terminal peptides of 
proteins. After the attachment of prenyl groups, the “-AAX” tripeptide is then cleaved by a 
“CAAX” protease. The final step during protein prenylation is methylation of the free cysteine 
residue by a cysteine methyltransferase (234).  
 
Necessity of prenylation for proper cellular function in eukaryotes. Since the initial 
discovery in the 1970s of fungal mating pheromones as prenylated eukaryotic peptides, over 100 
human proteins that undergo this modification have been identified (235-238). These include 
nuclear lamins, which are required for proper cell cycle regulation and division, and guanine 
nucleotide-binding regulatory proteins (G-proteins), which function in cellular signaling 
pathways (239). In order for these proteins to properly function, they must be localized to 
nuclear membranes. This is achieved via prenylation, as this modification increases the 
hydrophobicity required for membrane insertion (240). Disruption of the prenylation process at 
any one of these steps has negative impacts on protein function. For example, studies of the 
prenylation of nuclear lamin A in Chinese hamster ovary (CHO-K1) cells revealed that 
attachment of a prenyl group to the protein was required for proper localization to the nuclear 
membrane, since site directed mutagenesis of the “CAAX” motif or chemical inhibition of the 
PTM resulted in an accumulation of the protein in the nucleus (241). Similarly, it was 
demonstrated that chemical inhibition of isoprenoid synthesis inhibited the association of two 
subunits (β and γ) of the heterotrimeric G-protein with the cellular membrane in Spodoptera 
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frugiperda (Sf9) cells (242). Processing of prenylated proteins by CAAX proteases is necessary 
for proper protein function as was shown in a S. cerevisiae mutant of both CAAX proteases in 
which Ras could not be properly localized to the cell membrane (243). Finally, it was 
demonstrated in S. cerevisiae that a mutation of the STE14 carboxyl methyltransferase inhibited 
the methylation of prenylated a-factor mating pheromone (244). Although the pheromone was 
properly localized to the cell membrane, it could not be properly secreted from the cells. 
Collectively, these studies suggest that all steps of the prenylation pathway are required in order 
to maintain proper protein function. 
 
Prenylation as a PTM in prokaryotes. Prenylation in prokaryotes has not been well studied, 
particularly compared to work in eukaryotes. Indeed, ComX from Bacillus species is the only 
prenylated protein thus far to discovered in prokaryotes (245). ComX is a pheromone required 
for the quorum sensing ComPA two-component system in B. subtilis (246, 247).  Upon sensing 
an extracellular accumulation of the ComX pheromone, a phospho-relay system begins, with the 
autophosphorylation of the sensor histidine kinase (ComP), and subsequent phosphorylation of 
the response regulator (ComA) (248, 249). This then allows for the activation of genes involved 
in competence, including further production of comX/ComX (250). The ComX peptide 
undergoes post-translational modifications before it is secreted into the environment, whereby 
the attachment of a prenyl group promotes the formation of the peptide into a ring structure (251, 
252). 
 
In order to study the ComX pheromone, several B. subtilis strain variants of the peptide, along 
with putative prenyltransferase ComQ, were recombinantly expressed in E. coli (245). 
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Subsequently, variants of ComX ranging from 5-10 amino acids were purified and analyzed by 
mass spectrometry. This analysis revealed the presence of farnesyl or geranyl groups on 
conserved tryptophan residues. Furthermore, prenylation of ComX was determined to be 
required for proper function of ComX, as synthetic unmodified ComX peptides could not induce 
expression of srfA, a ComPA controlled gene. An additional study investigating prenyl group 
specificity revealed that ComX of B. subtilis strains 168 and RO-C-2 was farnesylated at the 
conserved tryptophan residue, while the pheromone in strains RO-E-2, RO-H-1, RS-B-1, RO-B-
2 contained a geranyl modification (253). The same group demonstrated in vitro prenylation of 
ComX by ComQ, and suggests that ComQ acts as a prenyltransferase based on a conserved 
“DDXXDD” motif, and conserved aspartic acid residue characteristic of such enzymes (254). 
Unlike that classically observed in eukaryotic protein prenylation, a consensus motif where this 
modification occurs in ComX synthesis has yet to be discovered (255). 
 
Prenylation of non-protein targets in prokaryotes. The prenylation of metabolites, involved in 
synthesis of the cell wall, cell membrane, and RNA, occurs in prokaryotes in order to form 
functional cellular compenents. The process of cell wall assembly occurs via a series of steps, 
many of which involve prenylation (256). Specifically, undecaprenyl pyrophosphate synthase 
(UppS) catalyzes formation of prenyl-containg moiety undecaprenyl pyrophosphate, which is 
dephosphorylated by undecaprenyl pyrophosphate phosphatase (UppP), forming bactoprenol 
(257). This reversible dephosphorylation is required for the recycling of N-acetylmuramoyl 
(NAM) peptides and N-acetylglucosamine (NAG) subunits for cell wall synthesis (258). 
Additionally, components of the cell membrane, or more specifically, electron transport chain 
(ETC), require the attachment of prenyl moieties for functionality. This includes quinones, which 
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transfer protons and electrons among the protein complex of the ETC. The synthesis of these 
energy carriers occurs via the attachment of a prenyl group to a head group by a 
prenyltransferase (259). Specifically, the synthesis of menaquinone occurs by the condensation 
reaction of a prenyl side chain and 1,4-dihydroxy-2-naphthoate (DHNA) by a DHNA 
prenyltransferase. Likewise, ubiquinones are synthesized by prenyl attachment to p-
hydroxybenzoate (PHB). An additional energy component of the electron chain, heme O, is 
synthesized by the condensation reaction of protoheme IX and a prenyl group catalyzed by 
protoheme IX farnesyltransferase (260). Lastly, and the most recently to be discovered, is the 
prenylation of RNA in some Gram-negative organisms (261). The geranylation of 5-
methylaminomethyl-2-thiouridine (mnm5s2U) and 5-carboxymethylaminomethyl-2-thiouridine 
(cmnm5s2U) is mediated by SelU, resulting in possible decreases in frame-shifting or altered 
RNA localization. 
 
 
Project aims. The aim of this project is to investigate novel, and as yet unexplored, post-
translational modification mechanisms in S. aureus. The first aim is to expand on our 
understanding of ECF sigma factor regulation to determine whether the process of regulated 
intramembrane proteolysis controls the activity of σS in S. aureus. This will begin with a 
characterization of a putative PrsW homolog contained within the genome of this organism. The 
second aim will be to explore proteolysis as a post-translational regulatory mechanism during 
stress response. Accordingly, the role and substrate preference of two house-keeping proteases, 
HtrA1 and HtrA2, will be elucidated. Finally, the third aim will be to explore the process of 
prenylation in prokaryotes, a process which is well understood in eukaryotes, but almost ignored 
in prokaryotes. This is justified by the observation that CAAX proteases and other prenylation 
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machinery exist in bacterial genomes, thus their potential role in S. aureus biology will be 
investigated. Collectively, the studies performed herein will expand on the knowledge of 
regulatory mechanisms in S. aureus that contribute to cellular homeostasis and pathogenesis. 
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CHAPTER 2: 
 
THE MEMBRANE PROTEIN PRSS MIMICS σS IN PROTECTING 
STAPHYLOCOCCUS AUREUS AGAINST CELL WALL-TARGETING ANTIBIOTICS 
AND DNA-DAMAGING AGENTS 
 
Note to reader. This chapter was previously published as a manuscript (262), and has been 
included with permission from the publisher (Appendix 1). 
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CHAPTER 3: 
 
THE HTRA1 AND HTRA2 PROTEASES IN STAPHYLOCOCCUS AUREUS PROVIDE 
OVERLAPPING DEFENSE AGAINST EXTRACELLULAR STRESSES 
 
Abstract. High temperature requirement enzymes are commonly referred to as “protease-
chaperones” because of their ability to mediate both protein degradation and folding. These 
housekeeping proteases are conserved amongst prokaryotes and eukaryotes and are involved in 
repairing a wealth of cellular damage in response to stress. Staphylococcus aureus encodes two 
such enzymes, named HtrA1 and HtrA2, which have previously been implicated in the 
regulation of pathogenesis, seemingly though modulation of Agr activity. Work presented herein, 
however, demonstrates that single and double htrA mutants of S. aureus do not exhibit alterations 
in agr expression, or virulence determinant production, suggesting that previous observations 
were a consequence of unintended mutations acquired during strain construction. To understand 
the role of these proteases in S. aureus physiology we first determined that, while transcription of 
the htrA genes is moderate under standard conditions, it is increased in response to extracellular 
stressors that induce protein, DNA, and cell envelope damage. Furthermore, we found that htrA 
mutant strains are more sensitive to elevated temperatures, alterations in pH, ferrous-ion 
mediated oxidative stress, DNA damage, and LL-37 exposure,. Given that the role of proteases is 
best understood by determining their substrates, we also performed a yeast-2 hybrid screen to 
identify proteins that interact with HtrA1 and HtrA2. We identified several cellular components 
that are involved in the response to pH alterations (general stress protein SAUSA300_1685 and 
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Na+/H+ antiporter SAUSA300_0911), oxidation (NfrA), DNA damage (MutM, and a MutS2-
like protein), and antibiotic stress (MsrR and EmrB/QacA family drug resistance transporter 
SAUSA300_2298). Taken together, we suggest the HtrA enzymes in S. aureus engage in broad 
substrate recognition in order to fold or degrade proteins that are damaged in response to 
situations that result in protein and DNA damage within the cell. 
 
Introduction. Staphylococcus aureus is a major health concern, causing a multitude of diseases, 
accounting for millions of hospitalizations annually (18). Many of these infections are difficult to 
treat because of the ability of the pathogen to rapidly acquire antibiotic resistance to promote 
survival (263-265). Moreover, the success of S. aureus can be attributed to its many virulence 
determinants and their coordinated regulation during the infectious process. While virulence 
determinant expression is necessary to mediate disease causation, the pathogen must also 
effectively respond to a wealth of stresses, inducing conditions encountered within the host for 
successful infection. Accordingly, bacteria such as S. aureus have mechanisms in place to 
withstand stress and/or repair damage that occurs during times of unfavorable environmental 
conditions.  
 
One such response is the alleviation of misfolded or damaged proteins from the cell, as their 
accumulation can prove to be toxic. Therefore, mechanisms exist to repair proteins either by 
chaperone-mediated refolding or protease-induced degradation (155, 266). Towards this latter 
point, high temperature requirement proteases are housekeeping enzymes that fold or degrade 
misfolded or damaged proteins (184). Htr proteases belong to the S1 family of serine peptidases, 
and contain a signal sequence or transmembrane-spanning domain, proteolytic domain (with a 
catalytic histidine, asparagine, and serine triad), and at least one PDZ domain (188). These 
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proteases form oligomeric structures from 3 to 30 subunits large in order to create a functional 
degradation apparatus (185). Generally, proteolysis of misfolded proteins is thought to initiate by 
the interaction of targets with the PDZ domain(s) of the peptidase, which promotes entrance into 
the multimeric protease structure (192). From there, the protein is engulfed, and during 
conditions of increased temperature, exposed to the catalytic triad, and subsequently degraded. 
 
As the name implies, Htr proteases are characteristically involved in cell survival at elevated 
temperatures. Indeed, HtrA (or DegP) of Escherichia coli was discovered when a transposon 
mutant for its encoding gene was unable to grow at temperatures above 44 °C (185). In addition 
to heat stress sensitivity, E. coli htrA mutants have been shown to be more sensitive to oxidative 
stress (194). Similarly, investigations performed on Gram-positive htrA mutants reveal that these 
enzymes are necessary to combat a variety of extracellular stresses. Specifically, Bacillus subtilis 
mutants lacking two htrA family proteases, htrA (ykdA) and htrB (yvtA), are more sensitive to 
high temperature and hydrogen peroxide stress, compared to wild-type strains. The loss of htrA 
in closely related B. anthracis renders the pathogen more sensitive to increased temperature, 
oxidative stress, and ethanol or salt exposure (197). Additionally, htrA in Streptococcus mutans 
is required for resistance to elevated temperatures, oxidative stress, DNA damage, acidic pH, and 
increased osmolarity (198). 
 
In addition to their role in stress response, Htr proteases have also been implicated in the 
virulence of Gram-positive pathogens. In such situations, alongside their role in folding and/or 
degrading damaged proteins, these enzymes appear to function in the specific proteolysis of 
virulence determinants. For example, in Streptococcus pyogenes htrA mutants, the virulence 
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factors SpeB and Streptolysin S are not properly processed, suggesting a requirement for the 
protease in order to generate active forms of these proteins (200). Similarly, the secretion of 
glucan-binding proteins, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and enolase is 
altered in htrA mutants in S. mutans (198). Lastly, studies performed on htrA mutants of the 
highly-virulent B. anthracis strain Vollum show decreased production of S-layer proteins and 
neutral protease A (NprA), resulting in decreased virulence in guinea pig models of infection 
(197). 
 
A previous study performed on the two HtrA enzymes (HtrA1 and HtrA2) in S. aureus suggests 
that these proteases display strain-specific functionality (202). Specifically, in the COL 
background, an htrA1 htrA2 double mutant displayed sensitivity to elevated temperatures, a 
phenotype absent in the RN6390 background. In the RN6390 background, an htrA1 htrA2 double 
mutant was more sensitive to puromycin than the parental strain, a phenotype not observed in 
COL. Most striking, perhaps, was the observed lack of hemolysis displayed only in the RN6390 
htrA1 htrA2 double mutant, which was attributed to the disruption of normal Agr-mediated 
virulence factor secretion. 
 
The role of these proteases in S. aureus biology was of particular interest to our group as we 
have previously shown that HtrA1 protein levels are decreased in our prior study on prsS 
function (262). As it was found that prsS mutants are more sensitive to cell wall-targeting and 
DNA damaging agents, we sought to further explore the role of HtrA protease in the stress 
response of S. aureus. To this end, the role of htrA proteases in S. aureus was elucidated by 
performing transcriptional profiling and mutant analyses, as well as protein interaction studies, 
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demonstrating that expression of these enzymes is up-regulated in order to mediate survival in 
response to numerous stressors that elicit protein, DNA, and cell envelope damage. 
 
Materials and Methods. 
 
Bacterial strains, plasmids, and growth conditions. S. aureus, E. coli, and Saccharomyces 
cerevisiae strains used in this study are listed in Table 1. Strains were grown as previously 
described, unless otherwise indicated (175). S. aureus was grown in 100 ml tryptic soy broth 
(TSB) and E. coli was grown in 100 ml lysogeny broth (267), both with a 1:2.5 flask:volume 
ratio, at 37°C with shaking (250 rpm). S. cerevisiae was grown in 100 ml yeast extract-peptone-
dextrose (YPD) broth with a 1:2.5 flask:volume ratio, at 30°C with shaking (250 rpm). When 
required, antibiotics were added to media at the following concentrations: ampicillin, 100 µg ml
-1 
(E. coli); chloramphenicol, 5 µg ml
-1
 (S. aureus); erythromycin, 5 µg ml
-1
 (S. aureus); 
lincomycin, 25 µg ml
-1
 (S. aureus); and tetracycline, 5 µg ml
-1
 (S. aureus). 
 
Table 1. Strains, plasmids, and primers used in this study. 
Strain, plasmid, or 
primer 
Genotype or description Reference or source 
E. coli   
DH5α Cloning strain Salisbury et al., 1972 
DC10B Cloning strain Monk et al., 2012 
   
S. aureus   
RN4220 Restriction-deficient transformation recipient Lab stocks 
RN6390 Wild-type laboratory strain Lab stocks 
USA300 USA300-HOU MRSA isolate cured of pUSA300-HOU-MRSA Kolar et al., 2011 
NE1141 USA300 JE2 htrA1::bursa aurealis, htrA1- Fey et al.,  2013 
CNK2131 USA300 htrA1::bursa aurealis, htrA1- This study 
CNK2132 USA300 htrA2::tet, htrA2- This study 
CNK2133 USA300 htrA1::bursa aurealis htrA2::tet, htrA1- htrA2- This study 
CNK2136 RN4220 pMK4::htrA1, htrA1+ This study 
CNK2137 RN4220 pMK4::htrA2, htrA2+ This study 
CNK2138 USA300 htrA1::bursa aurealis pMK4::htrA1, htrA1+ This study 
CNK2139 USA300 htrA2::tet pMK4::htrA2, htrA2+ This study 
CNK2142 RN4220 pAZ106::htrA1-lacZ, htrA1+ This study 
CNK2143 RN4220 pAZ106::htrA2-lacZ, htrA2+ This study 
CNK2144 USA300 pAZ106::htrA1-lacZ, htrA1+ This study 
CNK2145 USA300 pAZ106::htrA2-lacZ, htrA2+ This study 
CNK2233 RN6390 htrA1::bursa aurealis htrA2::tet, htrA1- htrA2- This study 
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Table 1 (Continued) 
Strain, plasmid, or 
primer 
Genotype or description Reference or source 
S. cerevisiae   
AH109 Y2H transformation recipient strain, HIS3- Clontech 
   
Plasmid   
pAZ106 Promoterless lacZ suicide vector Kemp et al., 1991 
pMK4 Gram positive shuttle vector Sullivan et al., 1984 
pLES106 pAZ106::htrA2 This study 
pLES113 pAZ106::htrA2::tet This study 
pCNK2134 pMK4::htrA1 This study 
pCNK2135 pMK4::htrA2 This study 
pCNK2140 pAZ106::htrA1-lacZ This study 
pCNK2141 pAZ106::htrA2-lacZ This study 
pOAD Y2H prey plasmid containing GAL4 activation domain, leu2+ Hudson et al., 1997 
pBDC Y2H bait plasmid containing DNA binding domain, trp1+ Millson et al., 2003 
   
Primer   
OL181 ATG GGA TCC CAA GCT GCA GGA GCG GTT  
OL182 ATG ATG GCA TGC CCC ACT TCG TCT TGA GAT GC  
OL183 GAC GAT GTA TCT AGA AAA CAA  
OL184 TTG TTT TCT AGA TAC ATC GTC   
OL761 GAC CAT GCA GAG GAT GAT GC  
OL1963 AAT ACC ACT ACA ATG GAT GAT G  
OL1964 TGC ACG ATG CAC AGT TGA AG  
OL1966 CGA TTC ATA GAT CTC TGC AGG  
OL2536 AGT TTG CCA CGT ATC TT  
OL2537 TTA GCT AAG ACC TGC ATC  
OL3140 ATG GGA TCC GTA CAA GTT ACG ACA TAT TTA C  
OL3141 ATG ATG GTC GAC CCT AAG AAT GTA ATG AGT AGG CTC  
OL3142 ATG GGA TCC GTG AAG CGG ACA ATC TTA ATT TAG  
OL3143 ATG ATG GTC GAC CAA TAC CTT GTT GAG GGC TTG ATC  
OL3162 ATG GGA TCC GCA CCA CGT TTC AAA GGT GC  
OL3163 ATG GAA TTC CAA TTT TAA GTA CAG CAA TAT C  
OL3164 ATG GGA TCC GAG CTA TTA AAC AAA TAT CCA G  
OL3165 ATG GGT ACC GCA TCG AGC TGT CTG AATC  
OL3451 GGT AAC GCA GGT GGC GCA TTA GTA G  
OL3452 CTA CTA ATG CGC CAC CTG CGT TAC C  
OL3453 GTA ACG CGG GTG GTG CTG TCG TC  
OL3454 GAC GAC AGC ACC ACC CGC GTT AC  
OL3485 ATG ATG CAG CTG TCA GAT TTT AAT CAT ACA GAT C   
OL3486 ATG ATG CCA TGG TTA TCT AAA GAA ATC TCT ATC  
OL3487 ATG ATG CAG CTG GAT ATT GGT AAA AAA CAT GTA ATT C  
OL3488 ATG ATG CCA TGG TTA TTT TAG TTT AAT ATT AAT TTC TTT C  
* Underline denotes restriction enzyme site. 
 
Construction of htrA1, htrA2, and htrA1 htrA2 double mutant strains. A USA300 JE2 htrA1 
mutant (NE1141) was obtained from the Nebraska Transposon Mutant Library (268). From this 
strain, a phage lysate was generated for Φ11-mediated transduction of USA300 HOU. The 
resulting strain CNK2131 was confirmed by PCR analysis using OL3162, located upstream of 
htrA1, and transposon-specific primer OL1472 (see Table 1 for all primers). In order to construct 
an htrA2 mutant, a novel XbaI site was introduced via SOEing PCR at the 323rd base-pair of 
htrA2 (total gene size = 2.3 kb), as described by us previously (175). This construction was 
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amplified, using primer pairs OL181/184 and OL183/182 and cloned into plasmid pAZ106 
(269); with transformants confirmed by restriction digest, creating plasmid pLES106 (see Table 
1 for all plasmids). A tetracycline cassette with XbaI sites at each end was generated as described 
previously (270) and ligated into pLES106, creating pLES113. RN4220 was electroporated with 
this construct as previously described (175), with co-integrants confirmed by Southern blot. Co-
integrants were resolved via Φ11 mediated transduction into strain USA300 HOU, selecting for 
tetracycline resistance (indicating presence of the cassette) and erythromycin sensitivity 
(indicating loss of the plasmid). Correct construction was confirmed by PCR, creating strain 
CNK2132. An htrA1 htrA2 double mutant was constructed by Φ11-mediated transduction of 
USA300 HOU htrA1::bursa aurealis into HOU htrA2::tet, and confirmed by PCR, creating strain 
CNK2133. Sequential Φ11-mediated transduction of USA300 HOU htrA1::bursa aurealis and 
HOU htrA2::tet into RN6390 was performed to create strain CNK2233. 
 
Construction of htrA1 or htrA2 complement strains. An htrA1 or htrA2 complement strain 
was constructed by first amplifying the htrA1 or htrA2 promoter and coding region using primer 
pair OL3140/3141 (htrA1) or OL3142/3143 (htrA2). Following this, the amplification products 
were cloned into the Gram-positive shuttle vector pMK4 (271) via transformation of DC10B 
(272), creating pCNK2134 for htrA1 or pCNK2135 for htrA2. S. aureus RN4220 was 
electroporated with pCNK2134 or pCNK2135, with clones confirmed using gene-specific primer 
OL3140 for htrA1 or OL3142 for htrA2 and plasmid-specific primer OL1057, creating strains 
CNK2136 (htrA1) or CNK2137 (htrA2). Phage lysates from these strains were generated for the 
transduction of a USA300 HOU htrA1 or USA300 HOU htrA2 mutant, again via Φ11. The 
38 
 
resulting complement strains, CNK2138 (htrA1) and CNK2139 (htrA2), were again confirmed 
by PCR. 
 
Construction of htrA1 or htrA2 lacZ-reporter fusion strains. In order to construct htrA1-lacZ 
and htrA2-lacZ reporter fusion strains, the htrA1 or htrA2 promoter regions were amplified using 
primer pair OL3162/OL3163 or OL3164/OL3165, respectively. The PCR product was ligated 
into pAZ106 (269), and transformed into DC10B (272), creating pCNK2140 for htrA1 or 
pCNK2141 for htrA2. S. aureus RN4220 was electroporated with pCNK2140 or pCNK2141, and 
the recombination event was verified using gene-specific primer OL3162 for htrA1 or OL3164 
for htrA2 and plasmid-specific primer OL761, creating strains CNK2142 for htrA1 and 
CNK2143 for htrA2. These verified clones were used to generate phage lysates to transduce 
USA300 HOU via Φ11-mediated transduction, with strains CNK2144 (htrA1) and CNK2145 
(htrA2) were again confirmed by PCR. 
 
Quantitative real-time PCR (qPCR). qPCR to measure levels of agrB using primer pair 
OL2536/2537, standardized to 16 S rRNA levels, was performed as previously described (273). 
Data is presented from at least three independent experiments. 
 
β-galactosidase measurement assays. β-galactosidase activity was measured as previously 
described (274) in the following growth conditions: TSB under standard conditions, TSB 
containing sub-inhibitory concentrations of chemical stress agents, RAW 264.7 murine 
macrophage-like cells, and THP-1 human monocytic cells. Native and background levels of β-
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galactosidase activity were subtracted from all calculations. Data is presented from at least three 
independent experiments. 
 
Heat stress assay. Exponentially growing USA300 wild-type and its htrA1, htrA2, and htrA1 
htrA2 mutant strains were washed 3 times with PBS. Cells were resuspended in PBS, and grown 
at 48 °C for 90 minutes. Percent recovery at 30-minute intervals was determined by comparing 
pre-exposure CFU/ml counts to post-exposure CFU/ml counts. Data is presented from at least 
three independent experiments. 
 
Extended pH shock assay. Exponentially growing USA300 wild-type and its htrA1, htrA2, 
htrA1 htrA2 mutant, and htrA1 and htrA2 complement strains were washed 3 times with PBS. 
Cells were resuspended in PBS adjusted to pH 2.2 with 6M HCl (for acid shock) or pH 11.8 with 
1M NaOH (for alkaline shock). Cultures were incubated shaking at 37 °C, and the percent 
recovery determined by comparing pre-exposure CFU/ml counts to 15 minutes post-exposure 
CFU/ml counts. Data is presented from at least three independent experiments. 
 
UV irradiation assay. UV irradiation assays were performed as previously described with the 
following minor modifications (183).  Briefly, exponentially growing USA300 wild-type and its 
htrA1, htrA2, and htrA1 htrA2 mutant strains were serially diluted to 1 x 10
-6
 cells. Cultures were 
plated at 10
-4
, 10
-5
, and 10
-6
 dilutions, and exposed to UV irradiation at 800 μJ/cm2 using a CL-
1000 UV Cross-linker. Percent recovery was determined by comparing UV-irradiated samples to 
untreated samples. Data is presented from at least three independent experiments. 
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Ferrous ion oxidative stress assay. Ferrous sulfate was added to a final concentration of 20 mM 
to exponentially growing USA300 wild-type and its htrA1 htrA2 mutant strain. Additionally, 4-
O-acetyl 2, 2, 6, 6 tetramethyl-piperidin-1-oxyl (A-TEMPO) or 4-OH 2, 2, 6, 6 tetramethyl-
piperidin-1-oxyl (4OH-TEMPO) was added separately to cultures at a final concentration of 20 
mM. Flasks were incubated statically at 37 °C, and the percent recovery determined by 
comparing pre-exposure CFU/ml counts to 1 hour post-exposure CFU/ml counts. Data is 
presented from at least three independent experiments. 
 
LL-37 killing assay. Assays using the antimicrobial peptide (AMP) LL-37 were performed, in 
triplicate, in a 96-well plate as previously described by us (275). After overnight static incubation 
at 37 °C, samples were serially diluted for enumeration in order to determine CFU/ml counts. 
 
Yeast 2-hybrid (Y2H) screen. A Y2H screen was conducted in order to detect interaction 
partners for both the HtrA1 and HtrA2 proteases in S. aureus cells. First, a prey plasmid library 
was generated by ligating pOAD (276) to fragmented S. aureus genomic DNA. To accomplish 
this, genomic DNA was first sonicated, subjected to 5’ and 3’-end polishing using the End-It™ 
DNA End-Repair Kit (Epicentre), and cloned into pOAD. In order to construct bait plasmids, the 
coding regions of htrA1 (S255A) and htrA2 (S619A) containing catalytic residue mutations from 
serine to alanine, were generated via SOEing PCR as previously described by our group (262). 
This was achieved using primer pairs OL3485/OL3452 and OL3451/OL3486 (htrA1) and primer 
pairs OL3487/OL3454 and OL3453/OL3488 (htrA2). The resulting fragments were cloned into 
pBDC (277) and confirmed by PCR analysis using plasmid-specific primer OL1966 and gene-
specific primer OL3485 (htrA1) or OL3487 (htrA2). Clones were also confirmed by Sanger 
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sequencing (MWG Operon) to verify the serine to alanine mutations were introduced. S. 
cerevisiae AH109 was then co-transformed with the bait and prey plasmids, and plated on 
synthetic defined (SD) media in order to select for interacting proteins as previously described 
(278). SD media contained 0.67% (w/v) yeast nitrogen base (YNB) without amino acids (BD 
Difco), 0.2% (w/v) complete supplement mixture (CSM)-histide-leucine-tryptophan (Sunrise 
Science), 2% (v/v) glucose, and 2% (w/v) agar. This defined media allows for the selection of 
colonies with interacting bait and prey plasmids that promote transcription of HIS3, one of the 
genes required for the synthesis of histidine in AH109. In order to identify prey plasmid inserts, 
plasmid DNA was extracted from the resulting transformants, amplified using plasmid-specific 
primer pair OL1963/1964, and analyzed by Sanger sequencing (MWG Operon). 
 
Results 
 
HtrA proteases do not influence agr activity in S. aureus. A previous study demonstrated that 
the simultaneous disruption of both htrA1 and htrA2 in S. aureus RN6390 resulted in decreased 
virulence determinant secretion, ablated RNAIII transcript, and decreased virulence in a rat 
model of endocarditis (202). Curiously, identical mutations in another background, COL, did not 
result in any of these outcomes. As such, we began our exploration of HtrA function in S. aureus 
by assessing hemolytic activity of the single mutants and htrA1 htrA2 double mutant strains in 
both the USA300 and RN6390 backgrounds. After overnight incubation on TSA containing 5% 
sheep blood, we determined that all mutant strains retained hemolytic activity (Figure 4A & B). 
To validate these findings we next performed qPCR on the agr locus in our RN6390 htrA1 htrA2 
and USA300 htrA1 htrA2 mutants, and again found no difference in expression compared to 
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wild-type strains (Figure 4C). Given that the agr locus of S. aureus is well known for its 
propensity of acquiring additional and unintended mutations during strain construction (279, 
280), we suggest that the previous findings regarding the role of HtrA proteases in S. aureus 
virulence factor production may be the result of such an event. 
 
The two HtrA proteases of S. aureus share moderate homology. The HtrA proteases in B. 
subtilis and B. anthracis are named HtrA and HtrB since they are structurally similar paralogs, 
resulting from a proposed genetic duplication. In both organisms, htrA and htrB, are not located 
in the same operon, but are instead encoded at distinct locations in the chromosome, and 
surrounded by different genes (Figure 5). The S. aureus genome also encodes two htr genes, 
htrA1 and htrA2, which are located 750 genes apart from each other. When comparing the 
genomic context of htrA1 and htrA2 in S. aureus with htrA and htrB of B. subtilis or B. 
anthracis, it becomes apparent that the genes are not encoded in similar loci in any organism (as 
determined by surrounding genes), suggesting a possible evolutionary divergence in both 
regulation and function of these enzymes. 
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A protein BLAST analysis of the B. subtilis HtrA and HtrB amino acid sequences demonstrated 
that there are 53% identical, with 72% positives (e=2x10
-140
) between the two enzymes. A 
similar analysis between the two enzymes in B. anthracis revealed that there are only 43% 
identical, with 62% positives (e=2x10
-106
). BLAST analysis of the S. aureus enzymes 
demonstrated that they are less homologous to each other than their Bacillal counterparts. 
Specifically, analysis of HtrA1 (SAUSA300_1674) and HtrA2 (SAUSA300_0923) revealed 34% 
identity and 57% positives (e=1x10
-60
) between the two enzymes (Figure 6). Moreover, when 
using BLAST analysis to compare homology of the HtrA enzymes in B. subtilis (HtrA/B) to 
those in S. aureus (HtrA1/A2), HtrA is more homologous to HtrA2, and HtrB is more similar to 
HtrA1. This is the opposite for B. anthracis (HtrA/B), wherein HtrA is more homologous to 
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HtrA1, and HtrB is more similar to HtrA2. Therefore, as the gene names in S. aureus do not 
consistently correspond to homology of HtrA or HtrB in the Bacilli, we suggest the current 
nomenclature of HtrA1 and HtrA2, although unorthodox, is perhaps the most appropriate.  
 
Interestingly, the lower homology of the two S. aureus enzymes compared to those in the Bacilli 
is noteworthy, and largely attributable to differences in amino acid length between the two 
enzymes: the HtrA1 protein in is 424 amino acids in length, almost half that of HtrA2 at 769 
amino acids (Figure 6). The increased size of the HtrA2 protein is a result of an extended N-
terminal region compared to other Htr enzymes (Figure 7). Indeed, HtrA2 of S. aureus appears to 
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be the largest Htr protein thus far identified, as bioinformatic analysis revealed that these 
enzymes can range from 57 (in Scalindua brodae) to 769 amino acids (HtrA2 of S. aureus) in 
length. Importantly, alignment analysis reveals conservation of the proposed catalytic residues: 
H144, D174, and S255 in HtrA1 and H504, D534, and S619 in HtrA2. Collectively, these results 
demonstrate that the Htr proteases in S. aureus likely did not result from gene duplication, as 
seen in the Bacilli. This may also suggest possible species-specific roles and adaptations for 
these proteases in the S. aureus cell. 
 
htrA1 and htrA2 are expressed under standard conditions. HtrA enzymes have been shown to 
be essential in a number of bacterial species only at elevated temperatures (281). As such, it is 
plausible that expression of their encoding genes is not required under standard conditions, but 
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instead, is induced only in response to stress. Such regulation occurs in E. coli where only 
minimal expression of degP is detectable at normal growth temperatures, yet, in response to heat 
shock, significant induction of degP transcription occurs as a result of σE-mediated upregulation 
(282). In contrast to this, however, htrA expression has also been demonstrated to be high under 
standard conditions in Campylobacter jejuni, wherein transcription of the protease is only 7.6-
fold lower than the highly transcribed 16S rRNA gene (283). In order to determine if the htrAs in 
S. aureus require transcriptional activation or are transcribed under standard laboratory 
conditions, we performed β-galactosidase assays on USA300 htrA1-lacZ and USA300 htrA2-
lacZ strains in TSB at 37 °C. Under these conditions, we observed robust expression of htrA1, 
and moderate expression of htrA2 during exponential phase, with peak levels occurring after 1h 
of growth (Figure 8A). Since htrA2 expression is significantly lower than that of htrA1 at all time 
points analyzed, the transcription of both enzymes was also assessed at elevated temperatures (42 
°C and 44 °C) to assess inducibility; however, no such effect was observed (data not shown). 
This finding is perhaps not surprising as previous S. aureus microarray studies show that neither 
htrA gene is upregulated in response to increased temperatures (284). Additionally, elevated 
temperatures do not alter transcription of htrA in Listeria monocytogenes (285). Taken together, 
these results suggest that the HtrA proteases of S. aureus are seemingly present in the cell during 
non-stress conditions, and do not require specific transcriptional activation for function, at least 
in the context of elevated temperatures. 
 
Chemical agents that lead to macromolecular damage enhance transcription of the htrA 
proteases. In addition to the observation that heat is required for the induction of htrA in a 
number of bacterial species (196, 199, 286, 287), many other stressors have also been shown to 
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elicit their expression, including penicillin-G, acidic pH, ethanol, NaCl, and oxidative stress 
induced by hydrogen peroxide or ferrous ions (194, 199, 283, 285, 287, 288). Given that heat 
does not lead to enhanced expression of either htrA gene in S. aureus we next sought to 
determine if any of these other conditions affected their transcription. Accordingly, a modified 
disk diffusion assay with a variety of chemical stressors was performed, followed by validation 
using β-galactosidase assays from TSB cultures containing sub-inhibitory concentrations of 
stress inducing agents, as previously described (273).  
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We determined that those chemicals known to induce protein, DNA, and cell wall damage elicit 
increased expression of both htrA1 and htrA2 (Figure 8B & C). Specifically, transcription of 
htrA1 is up-regulated in response to sub-inhibitory concentrations of N-lauroylsarcosine (8.3-
fold), vancomycin (6.7-fold), methyl methane sulfonate (MMS) (6.4-fold), hydrogen peroxide 
(5.2-fold), peracetic acid (4.6-fold), tween 20 (3.2-fold), and phosphoric acid (2.3-fold). The 
majority of these chemicals are capable of inducing protein damage by various mechanisms; for 
example, detergents (N-lauroylsarcosine and tween 20), acids (peracetic acid and phosphoric 
acid) and protein oxidation (hydrogen peroxide) all lead to protein denaturation (289, 290). Also 
contained within this subset of chemicals are agents that result in the damage of DNA by 
oxidation (hydrogen peroxide) or methylation (MMS) (291, 292). Curiously, the only antibiotic 
that affected transcription of htrA1 was vancomycin, a drug that causes cell wall damage by 
inhibiting transglycosylation during peptidoglycan synthesis (26).  
 
Upon analysis of htrA2 transcription, it was determined that fewer chemicals increased its 
expression compared to htrA1. These included SDS (2.8-fold), tween 20 (2.5-fold), N-
lauroylsarcosine (2.5-fold), and hydrogen peroxide (2.0-fold). All four of these compounds result 
in protein damage, either by denaturation (detergents SDS, tween 20, and N-lauroylsarcosine) or 
oxidation (hydrogen peroxide) (289, 290).  Additionally, up-regulation in response to hydrogen 
peroxide may be a consequence of DNA damage. Collectively, despite not being heat induced in 
S. aureus, it appears that these enzymes are upregulated by conditions that result in protein 
denaturation, the major outcome of heat stress in living systems. This corroborates work by 
others on htrA expression and function in different bacterial species (194, 199, 283, 285, 287, 
288). As such, the transcriptional inducibility of HtrA proteases in S. aureus speaks to a potential 
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role in protecting the cell against significant macromolecular damage, particularly at the level of 
protein, and to a lesser extent, DNA, damage. 
 
htrA1 and htrA2 production is increased in order to ameliorate damage induced by the host 
immune system. In addition to being stress-induced, previous transcriptional analyses of htrA 
genes have demonstrated their expression is increased during bacterial growth within 
macrophages or the phagosome (293-297). Indeed, a study performed on adherent and invasive 
E. coli suggested that such increases in expression may be directly attributable to stress 
conditions encountered within host cells, as htrA mutants are unable to withstand the oxidative, 
acidic and nutrient-depleted environments of the phagosome (293). In order to assess whether 
htrA expression is up-regulated during phagocytosis of S. aureus, transcriptional expression of 
both proteases was measured using ex vivo infection models. Upon analysis, at 24-hour post-
phagocytosis by murine macrophage-like RAW 264.7 cells, expression levels of htrA1 was 
determined to be increased 503-fold compared to levels in TSB (Figure 8D). Similar up-
regulation in expression was observed for htrA2, with 524-fold higher transcription levels 
compared to TSB (Figure 8D). In addition to this, infections were performed in a THP-1 human 
monocytic cell line demonstrating transcription of both proteases is further increased in this 
model by 11179-fold (htrA1) and 13501-fold (htrA2) (Fig 2D). Collectively, changes in 
expression profiles for the proteases in both RAW 264.7 and THP-1 cells suggest that 
transcription of these enzymes is up-regulated in response to altered environments and stress 
encountered within host cells. 
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HtrA proteases have a major role in the cellular response to protein denaturation. Previous 
studies have indicated that stressors found to induce expression of htrA genes may be indicative 
of conditions in which the enzymes are required for survival (196, 199). As such, we exposed the 
htrA mutants to a wide variety of stressors that may cause protein (or other macromolecular) 
damage, in efforts to determine in which conditions these enzymes are required. 
 
Our first analysis was performed under conditions of elevated temperatures, as many HtrA 
proteases in other bacteria have a major role in responding to this type of stress (298). Of note, 
however, is the previous work of others demonstrating that impaired survival of S. aureus htrA 
mutants is a strain-specific phenomenon, occurring in the COL background, but not RN6390 
(202). To determine the role of these enzymes in USA300, we tested the ability of the htrA 
mutants to survive when culture temperatures were shifted from 37 °C to 48 °C. In so doing, we 
observed that viability of the htrA mutants did indeed decline over time compared to the wild-
type strain (Figure 9A). Specifically, after 60-minutes the survival of the htrA2 single mutant and 
htrA1 htrA2 double mutant is 3.0-fold and 5.9-fold lower than the wild-type strain, while 
survival of the htrA1 mutant is unaffected. At 90-minutes post-exposure, percent recovery of the 
htrA1 (3.8-fold), htrA2 (5.3-fold), and double mutants (28.6-fold) are all significantly decreased 
compared to the wild-type strain. These results indicate that the two proteases perform similar 
roles in responding to increased temperature, an effect that appears to be additive upon loss of 
both enzymes, suggesting overlapping roles in protection. Moreover, these data are similar to 
those for S. aureus COL htrA mutants, again suggesting that unintended mutations acquired 
generating the RN6390 htrA1 htrA2 double mutant strain may influence the previously reported 
strain-specific variations. 
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It has previously been shown that in acidic conditions, htrA mutants in both L. monocytogenes 
and S. mutans are less able to survive than the parental strain (198, 285, 299). In addition, 
biochemical analyses have shown that the HtrA-family protein DegQ from E. coli exhibits 
optimal activity at slightly acidic pHs in vitro (300). These findings are thought to be explained 
by the fact that, as with increased temperature stress, alteration in environmental pH results in 
protein denaturation (290), necessitating the need for HtrA chaperone and/or protease activity. 
As such, we tested the ability of htrA mutants in S. aureus to withstand extreme alkaline or 
acidic pH environments.  
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Specifically, when exposed to an alkaline pH of 11.8 for 15 minutes, the survivability of the 
single htrA2 mutant is similar to that of the wild-type, with a <2-fold decrease observed (Figure 
9B). In contrast, the htrA1 single and htrA1 htrA2 double mutants have significant diminished 
viability, proving 2.0-fold and 4.3-fold less able to survive, respectively, than the parental strain. 
Importantly, complementation of htrA1 restores the ability of the htrA1 single mutant to survive 
at wild-type levels. When the same assessments were performed for highly acidic conditions (pH 
of 2.2), survival of the htrA2 mutant was again comparable to that of the wild-type (Figure 9C).  
Viability of the htrA1 mutant, however, was reduced by 2.4-fold, which was restored to wild-
type levels upon complementation with htrA1. In addition, the htrA1 htrA2 double mutant was 
further impaired in survival, returning a significant 14.6-fold decrease in recovery of viable cells. 
Taken together, these data suggest that the HtrA proteases mediate survival of S. aureus in 
response to extreme pH, likely via a role in circumventing toxicity caused by protein 
denaturation, and that there is some level of functional redundancy for these two enzymes in 
these conditions. 
 
HtrA enzymes are required to mediate the repair of DNA damage. A previous study in S. 
mutans revealed that HtrA protease mutants are more sensitive to the DNA-alkylating agent 
mitomycin C (198). This, coupled with the enhanced transcription of htrA1 in response to the 
DNA-alkylating agent MMS, led us to determine if these enzymes protect S. aureus cells against 
this kind of stress. Accordingly, we analyzed survival of the htrA mutants to lethal 
concentrations of the DNA damaging-agents ethidium bromide and MMS, but found no 
significant difference in viability compared to the wild-type strain (data not shown). 
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Interestingly, when we exposed strains to UV-irradiation, the htrA single mutants and the double 
mutant all had impaired recovery (Figure 10). Specifically, the highest decrease in survival 
(11.0-fold) was exhibited by the double mutant, followed by lesser decreases for htrA1 (5.4-fold) 
and htrA2 (2.8-fold) single mutants. Complementation of the single mutants was not possible as 
our group and others have previously reported that plasmid loss is >80% in response to UV 
exposure (183, 301). These data suggest that both enzymes are required for survival in response 
to damage caused by UV-irradiation.  
 
Oxidative damage to proteins or DNA is alleviated by the HtrA proteases. The requirement 
for antioxidants, along with protein chaperones, in order to resist oxidative stress has been well-
documented (31, 302). Indeed, circumventing oxygen-mediated stress is particularly important in 
pathogenic organisms, as this is a major component of host defenses against invading organisms.  
Of note, proteomic analyses in Helicobacter pylori have previously shown that HtrA abundance 
increases following exposure to hydrogen peroxide (303). This is perhaps to be expected as it has 
been suggested HtrA proteases recognize proteins with carbonylation modifications, a 
consequence of oxidation, in order to mediate degradation or refolding of damaged substrates 
(304). Additionally, oxidation of amino acid residues leads to alterations in protein side chains, 
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and tertiary structure, which can expose hydrophobic amino acids (289, 290). Such exposed 
hydrophobic regions are thought to be targets for HtrA proteases, as their substrate cleavage site 
is proposed to contain valine or isoleucine residues (300).  
 
Thus, in order to determine if the HtrA enzymes respond to oxidative damage in S. aureus, we 
first analyzed the impact of hydrogen peroxide on mutant survival, and found that they are 
seemingly unaffected by this kind of oxidative stress (data not shown). In order to determine if 
the HtrA proteases are involved in responding to damage induced by non-hydrogen peroxide-
derived oxidative stress, we next examined the ability of our mutants to withstand damage 
created by ferrous ions. When the htrA mutants were exposed to 20 mM ferrous sulfate, the 
single mutants displayed no alterations in survival (data not shown); however, the double mutant 
displayed a 3.2-fold decrease in viability compared to the wild-type strain (Figure 11). Given that 
the HtrA proteases are membrane-associated enzymes whose active sites are exposed to the 
cytoplasm, it is not clear which cellular compartment the observed defects result from. To 
resolve this, we used the antioxidants A-TEMPO and 4OH-TEMPO, similarly to that previously 
reported for htrA mutants of E. coli (194).  The reason for this is that, if the oxidative stress can 
be alleviated by A-TEMPO, a compound that remains in the membrane, this would perhaps 
suggest that damage is occurring to membrane-spanning proteins. In contrast, if this same stress 
is ameliorated by 4OH-TEMPO, it would suggest that protein damage is occurring in the 
cytoplasm of the cell. Interestingly, the sensitivity to ferrous sulfate was negated to at least wild-
type levels by both A-TEMPO and 4OH-TEMPO, suggesting a role for the proteases in repairing 
proteins localized in both the membrane and cytoplasm. With that said, A-TEMPO results in a 
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much more dramatic increase in survival, compared to 4OH-TEMPO, suggesting that these 
enzymes may be predominately responsible for repair of membrane-associated proteins.  
 
HtrAs are necessary to withstand membrane damage elicited by antimicrobial peptide 
(AMP) LL-37. Our A-TEMPO data above suggests that the membrane associated HtrA 
proteases may have a role in repairing damage to their local microenvironment. As such, their 
disruption may lead to issues with membrane and/or wall integrity in mutant strains. Such a 
contention is supported, in part, by the observation that the cell wall-targeting antibiotic 
penicillin-G inhibits the growth of htrA mutants in L. monocytogenes (202, 285). Therefore, in 
order to assess the role of HtrA proteases in responding to cell wall stress, we exposed our 
mutants to a variety of antibiotics that target this aspect of the cell. Upon analysis, we did not 
find differences when comparing MICs of the wild-type to mutant strains for all antibiotics 
tested. Interestingly, degP mutants of E. coli have previously been shown to be more sensitive to 
AMPs (305), so we next tested this kind of membrane stress with our collection of htrA mutants. 
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Of note, we observed increased sensitivity of all mutants to the human cathelicidin LL-37 
(Figure 12). Specifically, whilst exposure to lower concentrations (5 µg/ml and 10 µg/ml) 
elicited minor viability impairments compared to the parent (1.3-fold decrease for the htrA1 
mutant; 1.3-2.1-fold decrease for the htrA2 mutant, and 1.8-fold decrease for the htrA1 htrA2 
double mutant), we observed greater defects at higher doses (15 µg/ml of LL-37). Under these 
conditions we determined an 11.3-fold decrease for the htrA1 mutant, a 12.1-fold decrease for 
the htrA2 mutant, and a remarkable 48.0-fold decrease for the htrA1 htrA2 double mutant. 
Collectively, these data suggest that cell wall architecture is likely unaltered in htrA mutants; 
however, the absence of these proteases seemingly leads to issues with cell membrane stability. 
 
The HtrA1 and HtrA2 proteases interact with proteins involved in responding to 
extracellular stress. Although the necessity for HtrA proteases in the stress response of many 
bacteria has been established, the identities of native bacterial HtrA substrates are thus far scarce. 
Thus far only a few have been identified, including the acylated precursor of colicin A lysis 
protein (pCalm), K88 and K99 fimbriae, PapA pilin, and the extracytoplasmic adaptor protein 
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CpxP all found in E. coli (306-310) and the competence-stimulating peptide CSP in S. 
pneumoniae (311). Therefore, in order to identify proteins that interact with HtrA1 and HtrA2 
from S. aureus, we performed Y2H screens for each of these proteases.  
 
As such, we searched for clones exhibiting positive interactions between a prey plasmid 
(encoding a S. aureus library of genes) and an HtrA1 (S255A site-directed mutant) bait plasmid. 
From this screen, we identified 24 proteins as putatively interacting with HtrA1. The identified 
proteins can be organized into a number of different ontologies, including proteins involved in: 
maintaining cell envelope architecture, antibiotic resistance, stress response, protein metabolism 
and transport, and energy metabolism (Table 2). Importantly, HtrA1 was found to interact with 
itself, which is perhaps not surprising, as these proteases have been shown to form oligomeric 
structures (185). The most frequently identified interactor was MsrR, which is a member of the 
LytR-CpsA-Psr regulatory family of proteins, involved in maintaining cell envelope architecture 
under stress inducing conditions (312). In addition we found multiple proteins involved in 
antibiotic resistance, including drug resistance transporter SAUSA300_2298 of the EmrB/QacA 
family and drug resistance protein Flp, as interacting with the HtrA1 enzyme. Importantly, 
proteins involved in general stress responses were also identified, including the general stress 
response proteins SAUSA300_1685, flavin mononucleotide dependent NADPH oxidase NrfA, 
and a protein involved in maintaining proper cellular pH, Na+/H+ antiporter SAUSA300_0911. 
In addition enzymes required for protein synthesis/metabolism (pyridine nucleotide-disulfide 
oxidoreductase SUSA300_0576; aspartyl-tRNA synthetase AspS; and epoxyqueuosine reductase 
QueG) or secretion (secondary Sec system accessory protein Asp1) were found to interact with 
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the HtrA1 enzyme. This latter group is perhaps not surprising as HtrA enzymes have been 
demonstrated to be both chaperones and proteases (192), mediating protein turnover and export.  
 
Table 2. Interacting protein partners identified for HtrA1. 
Accession Number Protein Cellular Process Hits 
SAUSA300_1257 MsrR; LytR-CpsA-Psr regulatory family protein Maintain cell envelope 
architecture 
7 
SAUSA300_2298 Drug resistance transporter, EmrB/QacA subfamily Antibiotic resistance 4 
SAUSA300_0191 PtsG; PTS system, glucose-specific IIABC component Glucose transport 2 
SAUSA300_0576 Pyridine nucleotide-disulfide oxidoreductase Protein metabolism 2 
SAUSA300_1755 SplD; Serine protease Proteolysis 2 
SAUSA300_2386 Flp; Drug resistance membrane protein Antibiotic resistance 1 
SAUSA300_0668 MutS2 domain containing protein DNA recombination 1 
SAUSA300_0190 IpdC; Indolepyruvate decarboxylase Energy metabolism 1 
SAUSA300_1995 ScrR; Sucrose operon repressor Energy metabolism 1 
SAUSA300_2469 SdaAA; L-serine dehydratase, iron sulfur-dependent α 
subunit 
Energy metabolism 1 
SAUSA300_0445 GltB; Glutamate synthase, large subunit Energy metabolism 1 
SAUSA300_0687 CorC; Magnesium and cobalt efflux protein Ion transport 1 
SAUSA300_0911 Na+/H+ antiporter Maintain pH 1 
SAUSA300_1586 AspS; Aspartyl-tRNA sythetase Protein metabolism 1 
SAUSA300_1806 QueG; Epoxyqueuosine reductase Protein metabolism 1 
SAUSA300_2587 Asp1; Accessory Sec system protein Protein secretion 1 
SAUSA300_1674 HtrA1; High temperature requirement A1 protease Proteolysis 1 
SAUSA300_0218 Uncharacterized histidine kinase Signal transduction 1 
SAUSA300_2309 HssS; Histidine kinase Signal transduction 1 
SAUSA300_1897 C4-dicarboxylate ABC transporter Solute transport 1 
SAUSA300_1685 Putative general stress protein Stress response 1 
SAUSA300_0381 NfrA; Flavin mononucleotide dependent NADPH 
oxidase 
Stress response 1 
SAUSA300_1750 Putative NTPase Transcription 1 
SAUSA300_1143 TopA; Topoisomerase I Transcription 1 
 
Fewer proteins were identified as interacting partners for HtrA2 (again using a site-directed 
mutant, S619A), with most involved in similar processes to HtrA1 partners, including antibiotic 
resistance, stress response, protein secretion, and energy metabolism (Table 3). In addition to 
drug resistance transporter SAUSA300_2298, that was also identified for HtrA1, another 
antibiotic resistance protein, the MarR regulator family protein SAUSA300_0954, was identified 
as an interacting protein with HtrA2. Two proteins involved in the stress response were also 
identified as binding to HtrA2: the DNA-damage repair glycosylase MutM, which responds to 
oxidative stress damage (313), and the putative general stress response protein 
SAUSA300_1685. Almost half of the remaining proteins identified are involved in enzyme or 
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energy metabolism, again, suggesting that perhaps the HtrA proteases are involved in chaperone 
activity during non-stress inducing conditions. 
 
Table 3. Interacting protein partners identified for HtrA2. 
Accession Number Protein Cellular Process Hits 
SAUSA300_0757 Pgk; Phosphoglycerate kinase Pgk Glycolysis 2 
SAUSA300_0954 MarR regulator of unknown function Antibiotic resistance 1 
SAUSA300_2298 Drug resistance transporter, EmrB/QacA subfamily Antibiotic resistance 1 
SAUSA300_1635 MutM; Formamidopyrimidine-DNA glycosylase DNA damage repair 1 
SAUSA300_2047 ThiE; Thiamine-phosphate pyrophosphorylase Energy metabolism 1 
SAUSA300_2525 Fructosamine-3-kinase Energy metabolism 1 
SAUSA300_2443 GntK; Gluconate kinase Energy metabolism 1 
SAUSA300_1995 ScrR; sucrose operon repressor Energy metabolism 1 
SAUSA300_0315 NanA; N-acetylneuraminate Energy metabolism 1 
SAUSA300_1119 VfrB; ATP-binding protein of fatty acid kinase Fatty acid metabolism 1 
SAUSA300_2442 GntP; Gluconate permease Gluconate transport 1 
SAUSA300_0191 PtsG; PTS system, glucose-specific IIABC component Glucose transport 1 
SAUSA300_2615 GNAT acetyltransferase Metabolism 1 
SAUSA300_2504 yrhL-like subfamily of SGNH-hydrolases protein Metabolism 1 
SAUSA300_2587 Asp1; Accessory Sec system protein Protein secretion 1 
SAUSA300_1755 SplD; Serine protease Proteolysis 1 
SAUSA300_1705 Major facilitator superfamily (MFS) protein Solute transport 1 
SAUSA300_1685 Putative general stress protein Stress response 1 
SAUSA300_0707 Osmoprotectant ATP-binding permease protein Stress response 1 
SAUSA300_1440 Putative lipoprotein Unknown 1 
 
When one compares both Y2H screens, it becomes apparent that there are 6 proteins identified as 
interacting partners for both proteases (Table 4). This is perhaps expected, as a number of our 
analyses above have demonstrated seemingly overlapping roles in similar cellular processes for 
the two enzymes. Furthermore, a shared protein specificity has been documented in E. coli for 
the homologous HtrA proteases DegP and DegQ; both of whom cleave substrates in vitro at 
“V/Xaa” or “I/Xaa” sites (X=any amino acid; a=aliphatic amino acid) (314). 
 
Table 4. Interacting protein partners identified for both HtrA1 and HtrA2. 
Accession Number Protein Cellular Process Hits 
SAUSA300_2298 Drug resistance transporter, EmrB/QacA subfamily Antibiotic resistance 5 
SAUSA300_0191 PtsG; PTS system, glucose-specific IIABC component Glucose transport 3 
SAUSA300_1755 SplD; Serine protease Proteolysis 3 
SAUSA300_1995 ScrR; sucrose operon repressor Energy metabolism 2 
SAUSA300_2587 Asp1; Accessory Sec system protein Protein secretion 2 
SAUSA300_1685 Putative general stress protein Stress response 2 
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Discussion. Herein, we investigated the expression and role of the two HtrA proteases from S. 
aureus, and identity potential interacting partners for each enzyme. Previous work on these 
proteases in S. aureus demonstrated that they are required for Agr activation in strain RN6390, 
but not COL (202). Herein we observe no apparent HtrA-mediated control of Agr, as a mutant 
strain lacking both proteases in strains RN6390 and USA300 do not exhibit reduced hemolysis or 
differential agr expression. Furthermore, the same previous studies also indicated that htrA 
mutants in COL, are sensitive to heat, yet there is no difference in response to this stress in strain 
RN6390. Once again, our data in USA300 correspond to results from COL, as we demonstrate 
our USA300 htrA1 htrA2 double mutants are sensitive to elevated temperatures. Finally, 
increased sensitivity to the protein synthesis inhibitor puromycin, was demonstrated to be a 
phenotype exclusive to RN6390 htrA1 single and htrA1 htrA2 double mutants, and absent in the 
COL strain. When we tested sensitivity to puromycin of the USA300 protease mutants, we find 
no difference compared to wild-type strain (data not shown), again paralleling previous findings 
for COL. Taken together, we propose the unusual effects observed from the RN6390 htrA 
mutants in the study by Rigoulay et al. are likely the result of unintentional mutations in agr (and 
perhaps other loci) that were acquired during strain construction.  
 
In order to elucidate the roles of HtrA1 and HtrA2 in S. aureus physiology, we first assessed 
transcriptional profiles for each enzyme. From the literature it is clear that the expression of htrA 
genes is specific to individual bacterial species, with some transcribed constitutively, and others 
displaying more temporal regulation via environmental stress (281, 283). In S. aureus, we 
determined that these proteases are expressed during standard growth conditions, suggesting that 
presence of these enzymes in the cell is required either as a means to function as chaperones 
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under standard conditions or initiate a rapid response to protein damage requiring proteolysis. 
Although both proteases are transcribed under standard conditions, expression of htrA1 was 
observed to be higher than that of htrA2. This same pattern of expression for bacteria that encode 
multiple htrA genes has also been previously reported. For example, expression of htrA and htrB 
in B. anthracis are similar to that demonstrated for S. aureus (197), with that of htrA being 
significantly higher than htrB; which is almost undetectable, in both standard and nutrient-
limiting media. It is important to note that the difference in expression between the htrA genes in 
B. anthracis is much larger than that observed here, with this difference being attributed to 
divergent roles for these two enzymes within the cell. Since expression differences in S. aureus 
are not as drastic as those in B. anthracis, it speaks to the potential that HtrA1 and HtrA2 have 
more overlapping roles; a contention borne out by our mutant characterization findings.  
 
We also sought to determine if environments that induce cellular stress, and subsequent 
macromolecular damage, could increase expression of the proteases. Upon analysis, we found 
that, much like that reported for the enzymes in other bacteria, htrA gene expression in S. aureus 
is up-regulated in response to agents that damage proteins, DNA, and the cell envelope (194, 
199, 283, 285, 287, 288). Furthermore, we also noted a dramatic increase in expression of these 
enzymes in RAW 264.7 and THP-1 cell lines. This latter effect is in accordance within our 
environmental stress data as perturbations of the bacterial cell wall and exposure to reactive 
oxygen species (ROS), acidic environment, and nutrient depletion are all features of host defense 
mechanisms (315-317). Collectively, the increase in expression of htrA1 and htrA2 in response 
to chemical or immune system stressors, indicates that the enzymes are required to act as 
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chaperones or proteases, and increase in abundance when encountered with stress that 
necessitates repair or degradation of proteins. 
 
Following this, since previous studies on HtrA proteases have established the necessity for these 
enzymes in response to alterations in conditions that lead to protein misfolding or damage (184), 
we sought to determine their role in response to macromolecular damage. To this end, we show 
that the absence of the two proteases leads to increased sensitivity to a variety of stressors that 
result in protein damage. Specifically, in addition to the aforementioned inability of the htrA1 
htrA2 mutant to survival at elevated temperatures, the mutant is also more sensitive to both 
alkaline and acidic pH, conditions that disrupt protein structure. An explanation for this may 
come from our Y2H screen where we identified interaction of both HtrA1 and HtrA2 with 
SAUSA300_1685, a general stress protein. Although the function of SAUSA300_1685 has yet to 
be determined experimentally, bioinformatic analyses reveals that it is predicted to be a small 
membrane-localized protein. Additionally, the gene encoding this protein has previously been 
shown to be σB-regulated in both B. subtilis and S. aureus, and is increased in expression in 
response to alkaline shock in the latter organism (318, 319). As such, it is possible that 
SAUSA300_1685 serves to activate HtrA proteins in response to damage occurring by alkaline 
shock. In addition to this, a protein identified as an HtrA1 interacting partner, Na+/H+ antiporter 
SAUSA300_0911, may also explain the sensitivities seen for the protease mutants in response to 
altered pH environments. These transporters maintain neutral pH by transporting hydrogen ions 
outside of the cell, while importing sodium ions into the cytoplasm in response to cellular 
alkalinity (320). The utility of these enzymes has been demonstrated in a previous study whereby 
Na+/H+ antiporters from S. aureus confer resistance to pH stress in E. coli mutants lacking these 
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transporters (321). Moreover, it has been proposed that these antiporters remain in an inactive 
state, until the environmental pH becomes alkaline (322). This shift to active state is proposed to 
be a result of a conformational change in a disordered region of the enzyme. Thus, it is possible 
that the HtrA enzymes in S. aureus are involved in chaperoning this protein to proper functional 
conformation.  
 
We also demonstrate that the htrA1 htrA2 mutant sensitivity to ferrous sulfate-mediated 
oxidative stress can be rescued by both soluble and insoluble antioxidants, suggesting the activity 
of the proteases is required for repairing damaged proteins localized in both the membrane and 
cytoplasm. Notably, oxidative stress in the protease mutants is repaired to greater than wild-type 
levels by insoluble A-TEMPO, suggesting a substrate preference for membrane-localized 
proteins. From the Y2H analyses, we identified a potential interaction of HtrA1 with the enzyme 
flavin mononucleotide dependent NADPH oxidase (NfrA). Of note, NfrA has previously been 
demonstrated in S. aureus to mediate resistance to oxidative stress, as the purified protein is able 
to catalyze the reduction of flavin mononucleotide (FMN) in the presence of NADPH (323). 
Moreover, the promoter of nfrA contains a PerR box, a hallmark of genes induced in response to 
oxidative stress, suggesting that this protein is necessary to alleviate damage caused by this 
condition (324). Additionally, the necessity of this enzyme to repair oxidative damage was 
demonstrated wherein htrA mutants were more sensitive to host ROS in a murine model of 
infection (325). As such, perhaps the HtrA enzymes in S. aureus are required to mediate the 
repair or re-folding of NfrA that results from oxidative damage, in order for the enzyme to 
reduce intracellular oxygen radicals 
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In addition to stressors that elicit protein damage, we demonstrated that the HtrA enzymes also 
have a role in the response to DNA damage. Specifically, we determined that UV irradiation 
leads to a survival defect for both single htrA mutants and the double mutant. The detection of 
DNA-damage repair protein MutM, as an interacting partner for HtrA2, may explain the 
sensitivity of the htrA mutants to DNA damage. This DNA glycosylase has been demonstrated in 
B. subtilis to mediate repair of DNA damage induced by reactive oxygen species; repairing the 
toxic oxidized guanine base 8-oxo-G (326). Although UV-mediated DNA damage most 
commonly results in the formation of pyrimidine dimers, it can also lead to DNA oxidation (327, 
328), which MutM binds to and repairs. In addition to this protein, a protein of unknown 
function containing a MutS2 domain (SAUSA300_0668) was identified as an interacting partner 
for HtrA1. These proteins have mostly been implicated in suppressing homologous 
recombination of DNA in bacteria (329). However, in addition to this function, the MutS2 
proteins have also been shown to be required to repair oxidative DNA damage in H. pylori (330). 
As such, it is possible that the HtrA enzymes in S. aureus are required to chaperone the folding 
of MutM and SAUSA300_0668 so that they may bind damaged nucleotides in response to DNA 
stress. 
 
Finally, the protease mutants displayed increased sensitivity to LL-37-mediated stress. Since 
antibiotic susceptibility was not observed (in the context of other antimicrobial agents), and 
oxidative stress seems to be preferentially repaired in the membrane by the HtrA proteases, it is 
possible that the observed sensitivity to this compound is a result of damage to this cellular 
compartment upon protease deletion. One explanation for this may be by the observed Y2H 
interaction of the MsrR protein with HtrA1. Specifically, msrR mutants have been shown to be 
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more sensitive to cell wall-targeting antibiotics, including oxacillin, vancomycin, teicoplanin, 
and bacitracin (331). Indeed, it has been proposed that MsrR acts as a sensor protein to detect 
cell envelope damage, and plays a major role in mediating the cells response to this stress. As 
such, it is possible that in response to LL-37-mediated membrane damage, MsrR acts in a sensor 
relay with HtrA to initiate repair of damaged proteins. Similarly, another substrate involved in 
antibiotic resistance, the drug resistance transporter SAUSA300_2298 of the EmrB/QacA family, 
may account for the sensitivities of the mediate resistance to numerous toxic compounds, 
including ethidium bromide and lipophilic cationic antibiotics (332, 333). Moreover, a previous 
study demonstrated that resistance to the cationic antimicrobial peptide thrombin-induced 
platelet microbicidal protein-1 (tPMP-1) occurs in a QacA dependent manner (334). Therefore, 
we suggest that the absence of properly folded drug resistance transporter SAUSA300_2298 in 
protease mutant cells, leads to an enhanced susceptible to the cationic peptide LL-37. 
 
In addition to substrates that are involved in mediating the response to stress, proteins involved 
in normal cellular homeostasis and physiology were identified as potential HtrA interacting 
partners. Of particular interest is the identification of the secondary accessory Sec system protein 
Asp1 as a binding partner for both proteases. This protein is part of the accessory Sec system of 
S. aureus, which facilitates the secretion of serine-rich adhesin for platelets (SraP) (335). The 
identification of a secretion system component is in line with previous reports for the role of 
HtrA in secretion of several virulence factors in Streptococci (198, 200). As such, it is plausible 
that the HtrAs in S. aureus may serve as check-point proteins that associate with secretion 
machinery to ensure secreted determinants are properly folded before they are released into the 
extracellular environment.  
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In summary, we present evidence to suggest that the HtrA proteases in S. aureus are involved in 
the response to multiple stress situations. Studies herein provide new insights into stress 
responses that lead to macromolecular damage, which are currently mostly thought to be repaired 
by classical heat shock proteins (Hsps), including DnaK, GroES/EL, and Clp proteases. 
Although sensitivity to stress of the htrA mutants in numerous bacteria has been previously 
documented, understanding the mechanisms that these proteases utilize to ameliorate stress is 
currently lacking. To expand this, we identified putative interacting partners for both HtrA1 and 
HtrA2, including stress proteins, a DNA repair glycosylase, and antibiotic resistance enzymes. 
Each of these offer support for our findings that these protease have a clear role in the response 
to protein, DNA, and cell envelope damage. Collectively, we demonstrate that the HtrA 
proteases seemingly possess a partial overlap in functional, mediating the chaperoning and/or 
proteolysis of key elements of the global S. aureus stress response. 
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CHAPTER 4: 
 
THE DISRUPTION OF PRENYLATION LEADS TO PLEOTROPIC 
REARRANGEMENTS IN CELLULAR BEHAVIOR IN STAPHYLOCOCCUS AUREUS 
 
Note to reader. This chapter was previously published as a manuscript (336), and has been 
included with permission from the publisher (Appendix 2). 
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CHAPTER 5: 
 
FINAL DISCUSSION 
 
Discussion. Herein, we explore the role of the putative site-1 protease PrsS in S. aureus. We 
demonstrated that PrsS shares distant homology to PrsW counterparts in the Gram-positive 
organisms B. subtilis and C. difficile. This similarity in amino acid sequence presents the 
possibility that PrsS shares a similar functional role to that for PrsW in B. subtilis, wherein the 
enzyme cleaves the anti-sigma factor of σW to initiate the RIP cascade (167, 168). The site-1 
protease in B. subtilis is shorter in both amino acid content and contains less transmembrane 
domains than that in S. aureus. Specifically, PrsS contains three additional membrane-spanning 
domains and a large N-terminal extracellular extension not present in PrsW in B. subtilis. We 
suggest that this extended N-terminal domain, which is predicted from membrane topology plots 
to extend into the extracytoplasmic space, may be involved in sensing external signals. This has 
been observed in E. coli, wherein sensing of extracellular signals that initiate RIP of the σE 
system is mediated by RseB. This protein binds the anti-sigma factor RseA, inhibiting 
proteolysis, until damage is sensed (337, 338). Specifically, RseB senses the aggregation of 
misfolded lipoproteins that occur as a result of elevated temperature, in order activate the RIP 
cascade required to mediate the transcription of σE-regulated repair genes. Therefore, it is 
possible that instead of encoding an additional RIP protein in S. aureus, the N-terminal extension 
of PrsS senses stress signals, fulfilling the role of the accessory sensing protein RseB in E. coli. 
In addition to the dissimilarity in number of transmembrane domains between the proteins in B. 
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subtilis and S. aureus, the location of the predicted catalytic site residues in the protein homologs 
differs. Specifically, the catalytic site residues of PrsW in B. subtilis are located in the 
extracytoplasmic space, and those of PrsS are located in the membrane compartment. This would 
suggest that PrsS in S. aureus has other substrates, perhaps not related to RIP, which are located 
in the membrane. Alternatively, the orientation of the catalytic residues in this compartment also 
facilitates accessibility to an anti-sigma factor that is located in the transmembrane space. In 
order to identify a cognate anti-sigma factor for PrsS, a Y2H screen was used to screen for σS 
interacting partners. Although no apparent anti-sigma factors were identified using this method, 
we continued to explore the role of PrsS in S. aureus. 
 
Investigations of the function of PrsS began with transcriptional profiling in efforts to determine 
when the protease is active or conditions that increase its expression, indicative of stresses that 
promote activity of the enzyme. Accordingly, we identified the transcriptional start site and 
putative promoter consensus sequence, differing slightly from that of σA, which would not be 
atypical if the protease is controlled via σS-mediated transcription. The transcriptional control of 
RIP-related genes has previously been demonstrated in B. subtilis, wherein the σW anti-sigma 
factor rsiW is among the genes regulated by the sigma factor (172). In addition to this, a large 
intergenic region was identified upstream of the prsS start site, suggesting that the expression of 
the protease may be mediated by regulators that bind to this region. Subsequent to these 
promoter analyses, prsS-lacZ reporter fusions were used to determine that expression of prsS 
under standard laboratory conditions is minimal in all laboratory strains analyzed, with an 
increase in expression in the highly mutated RN4220. These observations were striking as they 
mirrored that previously observed for sigS (183), indicating the two enzymes may function in the 
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same or similar pathways. Moreover, these results may suggest that under standard conditions, 
the protease is not required, as the cleavage event to release any alternative sigma factor is not 
necessary. This inhibition of σS release from an anti-sigma, in turn, may prevent the auto-
transcription of the sigma factor that has previously been demonstrated (175). 
 
Since prsS transcription is either inhibited or not activated under standard conditions, we 
explored if stressors or alternative environments could promote an increase in expression of the 
protease. To achieve this, the transcriptional fusion strain was exposed to a library of compounds 
eliciting different types of stress, revealing that prsS is up-regulated in response to cell wall 
damage (ampicillin, bacitracin, cefotaxime, oxacillin, penicillin-G, phosphomycin and 
vancomycin) and DNA or oxidative damage (ciprofloxacin, H2O2, MMS, peracetic acid, and 
pyrogallol).  More dramatic increases in expression of prsS occurred during RAW 264.7 and 
human serum infection. The majority of the stressors that induce expression of prsS were also 
previously found to increase transcription of its putative cognate sigma factor (183). It is 
therefore plausible that prsS transcription is up-regulated in response to these types of damage, in 
order to promote cleavage of the σS anti-sigma factor, which would in turn, liberate σS to 
transcribe genes required to protect against such unfavorable conditions. 
 
In efforts to further demonstrate if the stress signals that increase transcription of prsS could be 
mapped to a physiological outcome, the sensitivity of prsS mutants to cell wall-targeting 
antibiotics and compounds that elicit DNA damage was also analyzed. It was determined that 
prsS mutants are sensitive to ampicillin, bacitracin, and penicillin-G, as well as the DNA-
damaging agents hydrogen peroxide and MMS. In conjunction with this, it was demonstrated 
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that PrsS likely functions as a protease, as prsS complements encoding catalytic site mutations 
(E215A, E216A) could not restore wild-type levels of resistance to the mutants for hydrogen 
peroxide or MMS stress. This was an important finding, as it provides support for the notion that 
proteolytic activity is required for this protein to function, further implicating it as a site-1 
protease in RIP. To this end, the proposed model is that, upon sensing of agents that elicit either 
the cell envelope or DNA damage response, PrsS initiates site-1 cleavage of an as yet unknown 
anti-sigma factor of σS (Figure 13). This cleavage is then putatively followed by site-2 cleavage 
by the RseP homolog that exists in S. aureus. The anti-sigma factor degradation that is initiated 
by site-1 and site-2 proteases may then be completed by the ClpXP protease. The further 
proteolysis by the cytoplasmic enzyme is required to remove the residual, inhibitory anti-sigma 
factor peptides from the sigma factor in E. coli (339). This series of events would allow the 
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release of σS so that it may associate with RNA polymerase to initiate transcription of a 
specialized subset of genes required for the response to specific stresses. 
 
Although the identity of an anti-sigma factor has yet to be discovered, proteomic analyses 
performed on prsS mutants led to the identification of numerous proteins that are altered in 
abundance upon disruption of this enzyme. These proteins include many that are involved in 
antibiotic resistance (Pbp2a, FemB, and HmrA) and maintaining DNA integrity (BmrA, Hpt, and 
Tag), each of which could explain the sensitivities exhibited by prsS mutants. These alterations 
in protein abundance seems to be mediated at the transcriptional level, as expression levels for 
each of the genes encoding these proteins were similarly decreased in both prsS and sigS 
mutants. This suggests that the differences in protein abundance in prsS mutants are a 
consequence of transcriptional regulation, putatively mediated by σS-directed transcription. 
Specifically, if these genes are part of a sigS regulon, then their transcription would require 
activation of σS, putatively initiated by PrsS cleavage of an anti-sigma factor. Thus, the absence 
of either the sigma factor or its activator likely results in the observed decreased expression of 
the genes in sigS and prsS mutants. 
 
Lastly, a role for PrsS in pathogenesis was established using ex vivo and in vivo models of 
infection. This was performed because sigS mutants were previously shown to be less able to 
survive in whole human blood, and were attenuated in severity of mortality and morbidity in a 
murine model of septic arthritis (175). Since prsS mutants are hypothetically sigS mutants as 
well, we sought to determine if the protease mutant had a similar phenotype in infection models. 
Importantly, we discovered cells deficient for prsS are less able to survive in whole human blood 
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and in the heart and lungs of mice during septic infections. The inability of prsS mutants to 
survive as well as wild-type strains during infection could result from inhibition of σS activation. 
Indeed, this observation that site-1 proteases are required for pathogenesis is similar to that for 
PrsW in C. difficile, wherein prsW mutants exhibit decreased colonization of the cecum in 
hamster models of infection (174). The necessity of RIP components in pathogenesis has been 
further demonstrated during investigations performed on site-2 proteases. Specifically, mutants 
of the site-2 protease Rv2869c of Mycobacterium tuberculosis were severely impaired in their 
ability to colonize lungs and cause pulmonary inflammatory lesions in murine models of 
infection (340). Taken together, the results further suggest that PrsS is a site-1 protease that 
induces σS activity upon the sensing of stress-inducing conditions, which promote activation of 
the sigma factor in order to respond to cellular damage. 
 
Following this, we progressed to investigations of the role of HtrA proteases in stress response, 
since in our study on PrsS, we determined that levels of HtrA1 were decreased in prsS mutants 
(262). This is line with previous studies that demonstrate that htrA expression is controlled by 
ECF sigma factors. For example, the activation of σE in E. coli and Salmonella typhimurium 
mediate the transcriptional up-regulation of stress response genes, including htrA (341, 342). 
Therefore, it is possible that the decreased level in expression of HtrA1 in prsS mutants is a 
result of σS inactivity. 
 
Despite the detailed studies performed on HtrA proteases in other bacteria, little is known about 
the role of these enzymes in S. aureus. From a previous study on these enzymes in S. aureus, it 
was determined that in strain RN6390 the HtrA proteases are involved in controlling the Agr 
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system (202), which serves as the master regulator of virulence. We determined herein, however, 
that this is not the case, as when both proteases are mutated in the same strain, hemolytic activity 
is retained and agrB expression remains unchanged. The absence of hemolysis and RNAIII 
transcript in the RN6390 htrA1 htrA2 mutant from the previous study suggests that an 
unintended mutation was acquired in the agr locus (or one that controls its expression) during 
strain construction. Indeed, mutations in this region are not uncommon during genetic 
manipulation of S. aureus as Agr is dispensable to the cell under standard laboratory conditions 
(279, 280). Therefore, as the HtrA proteases are likely not involved in Agr regulation, we sought 
to elucidate their actual function in the S. aureus stress response.  
 
As htrA proteases have been demonstrated to be encoded in operons that are upregulated in 
response to cellular stress (341, 342), we sought to identify conditions that increase the 
transcription of htrA1 and htrA2. To this end, transcriptional analyses of reporter fusions for both 
genes revealed they are each moderately expressed during standard conditions. This expression 
under non-stress inducing conditions may indicate that the enzymes are required in the cell to 
chaperone homeostatic protein folding. Further to this, the increased expression of both proteases 
in response to numerous stressors that lead to protein and cell envelope damage (including 
detergents, acids, oxidative agents, DNA-damaging compounds, and cell wall-targeting 
antibiotics) indicates the proteases are involved in repairing macromolecular damage. Likewise, 
transcriptional levels of htrA1 and htrA2 are increased in RAW 264.7 and THP-1 infection 
assays, providing evidence for the necessity of the enzymes to mediate damage encountered by 
the innate immune system. These results corroborate the findings from in vitro experiments 
wherein many of the stressors that are encountered during infection mimic the chemical agents 
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that increase expression of the proteases, including host reactive oxygen species and the acidic 
environment of the phagosome (315-317). Collectively, the upregulation seen in response to 
stress inducing chemicals or the environment suggests that these proteases are required to relieve 
toxicity resulting from the accumulation of damaged cellular components.  
 
Similar to that which has been demonstrated for HtrA enzymes in other bacteria, HtrA1 and 
HtrA2 in S. aureus seem to function in responding to several types of stress, which can lead to 
macromolecular instability. Specifically, the htrA1 htrA2 mutants exhibit a characteristic 
phenotype of this family of enzymes (185, 186, 343, 344): the inability to withstand elevated 
temperatures compared to wild-type strains. This decrease in viability of the protease mutants at 
higher temperatures may be a consequence of the inability of cell to properly degrade or refold 
damaged proteins. Indeed, evidence for the proteolytic activity of HtrAs in high heat was 
demonstrated in previous crystallization experiments in E. coli, wherein access to the proteolytic 
cavity of the enzyme is blocked until environmental temperatures increase (192). In addition to 
decreased survival in response to elevated temperatures, the protease mutants were found to be 
more sensitive to both alkaline and acidic pH alterations, conditions that have both been shown 
to affect protein stability (290). The sensitivity observed for the htrA1 htrA2 mutants in response 
to alterations in environmental pH may be attributed to the Na+/H+ antiporter 
(SAUSA300_1685) identified in a Y2H screen performed to detect HtrA interacting partners. 
Specifically, these classes of antiporters are necessary to ensure the proper passage of sodium 
and hydrogen ions across the cell membrane to maintain neutral pH (320). It is predicted that 
upon sensing an increase in alkalinity, the antiporters exhibit a conformational change that allow 
for the increase in influx of sodium ions into the cytoplasm to normalize cellular pH (345). 
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Similarly to that previously observed for htrA mutants in E. coli (194), the htrA1 htrA2 mutants 
of S. aureus are more sensitive to ferrous ion stress, which causes oxidative damage. The 
antioxidant 4OH-TEMPO and its derivative A-TEMPO were used in efforts to alleviate damage 
caused by ferrous ion exposure and determine location of substrates of the proteases. After 
treatment with either soluble 4OH-TEMPO, which will traverse the membrane into the 
cytoplasm of the cell, or A-TEMPO, which will remain in the membrane of the cell, survival of 
htrA1 htrA2 double mutant cells was restored to at least wild-type levels after exposure to ferrous 
sulfate. Furthermore, viability of the double protease mutant treated with A-TEMPO surpassed 
wild-type levels. This suggests that even though the catalytic residues for the enzymes are 
predicted to be located in the cytoplasm, HtrA-mediated repair of damage occurs predominately 
for membrane-localized proteins.  
 
In addition to their involvement in the repair of damaged proteins, we have proposed that the 
HtrA enzymes mediate a response to DNA damage, as mutants of these enzymes exhibit 
decreased survival after exposure to UV irradiation. This involvement of HtrA1 and HtrA2 in 
DNA damage is most likely not a result of direct repair of DNA by the enzymes, but instead the 
refolding or degradation of DNA repair enzymes. These may include enzymes that are required 
to repair DNA damage from UV exposure that can amanifest as the oxidation of nucleotides, as 
proteins involved in this type of damage response were identified in our Y2H screens. One of the 
proteins detected was DNA glycosylase MutM, which has been demonstrated to repair oxidized 
guanine base 8-oxo-G that result from an accumulation of ROS in B. subtilis (326). In addition to 
this, a MutS2-like protein (SAUSA300_0668) involved in mismatch repair was also identified as 
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a putative HtrA1 interacting protein. Indeed, this protein is required in H. pylori to repair G:C to 
T:A transversions that are a consequence of exposure to hydrogen peroxide or paraquat-mediated 
oxidation (330).  
 
Lastly, the double mutants were less able to survive increasing doses of the pore-forming AMP 
LL-37. Importantly, this is the only antimicrobial tested that had an adverse effect on survival of 
the protease mutants, suggesting that observed sensitivity to LL-37 is not a result of an altered 
cell envelope architecture that allows for increased uptake of the drug. Instead, insertion of LL-
37, which has been shown to cause membrane disorientation and swelling, may cause subsequent 
disturbance in the tertiary structure of membrane-embedded proteins (346). Therefore, the 
increased killing of htrA mutants by LL-37 may be in part a result of the aggregation of 
misfolded proteins in the membrane. One of these misfolded proteins may be the drug resistance 
transporter SAUSA300_2298 of the EmrB/QacA family that we identified as a possible 
interacting protein of both HtrA1 and HtrA2 (332, 333). Indeed, it is plausible that 
SAUSA300_2298 provides protection against LL-37 damage, as this family of drug transporters 
is has previously been shown to be required in Staphylococci for resistance to the cationic 
antimicrobial peptide thrombin-induced platelet microbicidal protein-1 (tPMP-1) (334). Taken 
together, these data suggest that the HtrAs recognize misfolded proteins, possibly by exposed 
hydrophobic amino acid residues, and subsequently act to refold or degrade them in order to 
promote cell survival. 
 
The last post-translational modification explored in this work was prenylation, as this process 
remains understudied in prokaryotes. To study this PTM in S. aureus, we assessed the impact of 
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the abrogation of prenylation in an ispA mutant strain. A mutant lacking IspA was chosen since 
the enzyme is required to catalyze the condensation reaction of geranyl diphosphate and 
isopentenyl diphosphate to form farnesyl diphosphate, or the prenyl moiety that is attached to 
proteins and metabolites (231). Indeed, we determined that ispA mutants are unable to properly 
synthesize farnesyl diphosphate at wild-type levels, suggesting that without this moiety, 
prenylation does not proceed correctly in these cells. The most apparent consequence of the 
abrogation of prenylation is the similarity of the cells in appearance to S. aureus small colony 
variants (SCVs) (347). Specifically, ispA mutants lack golden pigmentation, which likely stems 
from an inability of ispA mutants to synthesis farnesyl diphosphate, a precursor of 
Staphyloxanthin synthesis (348). Further to this, the prenylation mutants display a smaller colony 
size, a characteristic of SCVs that are unable to synthesize hemin, menadione, or thymidine, 
resulting in impeded growth rates (349). However, ispA mutant growth could not be restored to 
wild-type levels by chemical complementation with hemin, menadione, or thymidine to growth 
media. Instead the growth impairment of the ispA mutants was determined to be a result of 
decreased ATP levels, a cause that has also been attributed to slower growth of SCVs. The lower 
levels of ATP production in ispA mutants is likely due to an alteration in electron transport chain 
components, as prenyl groups are required to synthesize menaquinone and heme O (260, 350).  
 
Since the ispA mutants displayed striking alterations in colony appearance and size, we 
performed RNA-seq analysis in efforts to determine which cellular processes were affected in 
the cell. Results of this analysis revealed that over 700 genes were altered in expression in the 
ispA mutant compared to the wild-type strain. The alteration in expression affected genes 
involved in every cellular process, including cell wall architecture, protein metabolism, stress 
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response, regulation, and virulence. This alteration in genetic expression likely explains the 
pleotropic effects of ispA disruption on cell physiology. Specifically, the down-regulation of 
oxidative stress genes encoding superoxide dismutase SodM, multiple thioredoxin family 
proteins, and peptide methionine sulfoxide reductase MsrA2, coupled with the absence of the 
antioxidant Staphyloxanthin, all likely contributes to the decreased ability of ispA mutants to 
withstand a variety of oxidative stressors. Indeed, previous work on Staphyloxanthin has 
demonstrated that the membrane-bound carotenoid functions to scavenge free radicals and rescue 
S. aureus from oxidative killing (351). When examining proteins involved in this damage 
response, a study in S. aureus demonstrated that Sod enzymes are required to convert hydrogen 
anions to less toxic hydrogen peroxide and oxygen, as a proposed initial detoxification strategy 
against oxidative stress in the cytoplasm (352). Additionally, thioredoxins are required to reduce 
oxidized thiol-sulfide bonds in order to restore protein function (353). Similarly, the MsrA 
proteins in S. aureus have been found to be necessary for cell survival in response to hydrogen 
peroxide exposure, by reducing methionine sulfoxide to methionine, restoring proper amino acid 
structure (354). Thus, it is likely that the observed sensitivity of ispA mutants to ROS 
accumulation is a consequence of the inability of the cell to mount a multistep response against 
this type of damage. Specifically, since the prenylation mutants lack Staphyloxanthin they are 
unable to initiate a first line of defense against any oxygen radicals that penetrate the cell 
envelope. The cell is then further unable to properly eliminate ROS that have entered the 
cytoplasm due to decreased expression of enzymes required to reduce oxygen radicals that 
damage macromolecules.  
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Additional alterations in gene expression were found to provide a fitness advantage to ispA 
mutants. For example, increased expression of genes encoding cold shock proteins (Csp) A and 
C in the ispA mutant compared to the wild-type strains may explain loss of the growth defect for 
the mutant strain in cold temperatures. The cold shock enzymes have been demonstrated to be 
necessary for resistance to decreased temperature as deletion of cold shock proteins A, B, G, and 
E in E. coli results in cells that exhibit a growth defect and alteration in morphology at 15 °C 
(355). A similar growth defect effect was also observed for a cspA mutant of S. aureus that was 
incubated at 15 °C (356). The cold shock proteins have two mechanisms of action: the enzymes 
are capable of binding DNA to regulate gene transcription and also bind RNA to inhibit 
defective secondary structures in response to decreased temperature (357). Therefore, we 
propose that in cold environments there is an overproduction of CspA and CspC in ispA mutants 
that allows for the cell to effectively direct transcription of genes required to respond to this 
stress, perhaps by altering cell envelope structure. In addition to these alterations in stress 
response genes, the ispA mutants also transcribe alkaline shock genes encoding alkaline shock 
protein (asp23) and two asp23 family proteins at higher levels than wild-type strains. In S. 
aureus, asp23 is regulated by σB, whereby in response to stress, Asp23 production is up-
regulated to alleviate cellular damage (358). Specifically, it was found that in response to 
alkaline pH, Asp23 abundance is increased in the cytoplasm (359). Although the exact 
mechanism of action for Asp23 in mediating a stress response remains unclear, it was recently 
discovered that the enzyme is tethered to the cellular membrane by a small accessory protein, 
AmaP (360). This may suggest a role of the protein in sensing damage that perturbs the cell 
envelope. Thus, the increased survival of the ispA mutant compared to the wild-type in response 
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to alkaline shock may be in part due to the increased presence of Asp23 in the membrane, 
allowing for a heightened response to envelope stress. 
 
Since a hallmark of S. aureus SCVs is a variation in antibiotic susceptibility compared to non-
SCV strains, we tested numerous such compounds and determined that similarly to classic SCVs, 
ispA mutants are more resistant to aminoglycosidic antibiotics gentamycin, neomycin, and 
kanamycin and cationic peptides polymyxin-B and LL-37, likely due to lower ATP levels and 
membrane electrochemical gradients (347). This alteration in cell envelope energy level and 
charge leads to a membrane that is less permeable to these types of compounds (361). In 
contrast, and in opposition to that observed for classical SCVs, ispA mutants are more sensitive 
to cell wall-targeting antibiotics. Resistance to cell wall-targeting drugs in SCVs is attributed to 
the slower growth of the cells, resulting in a correlative decrease in uptake of cell wall antibiotics 
(362). Although ispA mutants exhibit a growth defect typical of classical SCVs, they are more 
resistant to cell-wall targeting antibiotics. As such, this opposite susceptibility profile reveals that 
ispA mutants are a novel type of SCV.  
 
The alterations in antibiotic resistances observed are likely due to alterations in cell envelope 
architecture in the mutant strain. Indeed, multiple analyses revealed that the cell envelope 
composition of ispA mutants is altered compared to wild-type strains. Specifically, when 
analyzed using transmission electron microscopy, the cell envelope is more diffuse, particularly 
at the septum of dividing cells. FAMEs analysis was used in efforts to determine the cause of this 
marked difference, revealing alterations in fatty acid composition of the membrane; with the ispA 
mutants possessing a higher proportion of longer fatty acid substrates than the wild-type strain. 
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This rearrangement of fatty acid composition may be a consequence of alteration in expression 
of numerous fatty acid biosynthesis genes detected by RNA-seq analysis, or a changed cell 
envelope, as prenyl substrates are required for peptidoglycan synthesis and membrane 
component biosynthesis (257-259). Moreover, an alteration in fatty acid composition of 
membrane lipids commonly results in changes in membrane fluidity. In addition to changing 
fatty acid chain length, saturation, branching or cyclization, or packing arrangement in the 
bilayer also dictate fluidity (363). Modifications to membrane components in order to increase or 
decrease membrane fluidity is a mechanism that bacteria utilize to protect the interior of the cell 
from a harmful extracellular environment (363). For example, this has been documented in 
bacteria where increases in temperature result in the synthesis of longer fatty acids and a switch 
from unsaturated to saturated fatty acids, leading to an increase in membrane fluidity (364). This 
alteration in membrane composition is a proposed activating stimulus for the membrane-
localized CpxA–CpxR two-component system in E. coli, which upregulates the transcription of 
heat shock genes in order to respond to damage induced by elevated temperatures (365). Thus, in 
order to analyze if such an alteration in membrane fluidity occurs as a result of the observed fatty 
acid differences of the ispA mutant compared to the wild-type strain, we first assessed how the 
mutants respond to exposure to compounds that readily insert into the cellular membrane. Upon 
analysis, it was determined that ispA mutants are more sensitive to killing by oleic acid, a free 
unsaturated fatty acid that more readily inserts into membranes with packed lipid bilayers, or a 
more hydrophobic environment (366). Conversely, the prenylation mutant was found to be more 
resistant to cell lysis mediated by the insertion of toluene, possible due to an inability of this 
organic solvent to transverse a membrane with increased hydrophobicity and fluidity (367). 
83 
 
Collectively, the results suggest that ispA mutants possess a more fluid membrane compared to 
the wild-type strain that compensates for a weakened cell wall.  
 
Although many of the alterations in prenylation deficient mutants can be attributed to the 
disruption of prenylated metabolite synthesis, the possibility of proteins being prenylated in 
bacteria cannot be dismissed. There exist two proteins in S. aureus that contain the “CAAX” 
motif that is the target of prenylation machinery in eukaryotic cells; therefore, if this PTM occurs 
as it does in eukaryotes, it is plausible that these two proteins are modified in such a manner. One 
of the proteins identified was TrmE, a tRNA modification GTPase (SAUSA300_2646). The 
identification of TrmE as a possible prenylated protein is of particular interest since the recent 
discovery that prenylation of RNA occurs in several Gram-negative bacteria (261). This SelU-
mediated geranylation of tRNAs facilitates the process of translation efficiency by adding 
hydrophobic moieties to the first anticodon. Another form of this tRNA modification has been 
demonstrated in Thermotoga maritima, whereby TrmE modifies uridine bases in the first 
anticodon of tRNAs (368). This may suggest that prenylation, as observed in Gram-negative 
bacteria, may also play a role in the modification of RNA via TrmE in Gram-positive bacteria.  
 
The second protein that contains a “CAAX” motif is a conserved hypothetical protein 
SAUSA300_1902, which shares homology with 3-carboxy-cis, cis-muconate lactonizing 
enzymes. These enzymes have been shown in soil-dwelling bacteria to function in the β-
ketoadipate pathway required to degrade aromatic compounds protocatechuate and catechol 
(369). Specifically, carboxy-cis, cis-muconate lactonizing enzymes convert 3-carboxy-cis,cis-
muconate to muconolactone, which is then further converted into tricarboxylic acid cycle 
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intermediates. The toxic precursors of protocatechuate and catechol are commonly found in soil 
environments, where Pseudomonas putida, for example, uses the β-ketoadipate pathway to 
degrade these compounds (370, 371). While the β-ketoadipate pathway is well studied in soil-
dwelling bacteria, this pathway has not been as well studied in other microorganisms. It is 
possible that an alternative role for this pathway may exist in organisms that are not exposed to 
the aromatic compounds found in soil environments. Specifically, the β-ketoadipate pathway 
may be involved in antibiotic resistance in human adapted pathogens. This is supported by a 
study where the enzymes of the β-ketoadipate pathway in clinical multi-drug resistant 
Acinetobacter baumannii strains are altered in expression compared to related non-drug resistant 
soil-dwelling species (372). As S. aureus is not a soil-adapted bacterium, it is not likely that 
SAUSA300_1902 functions to degrade toxic aromatic compounds derived from this 
environment. Instead, this enzyme may play a role in the degradation of aromatic antimicrobial 
compounds. The attachment of a prenyl group to this protein could facilitate its localization to 
the membrane, allowing it access to aromatic compounds that penetrate the cell envelope.  
 
Although it is possible that prenylation of proteins in S. aureus occurs at a “CAAX” motif, it is 
likely that prokaryotic prenylation of proteins proceeds via a unique mechanism, if indeed it 
occurs at all. This possibility of protein prenylation in prokaryotes, via a mechanism distinct 
from eukaryotes, is supported by the existence of prenylation machinery that is conserved 
amongst both Gram-positive and Gram-negative bacteria. Since the obvious prenyl transferases 
that are encoded in eukaryotes are absent from bacteria, it is plausible that the prenyl synthetases, 
IspA or IspB, are capable of the transferase activity required to attach a prenyl group to a protein. 
This hypothetical dual role of these enzymes has been suggested in literature because of the 
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conservation of the “DDXXD” motif in prenyl synthetases, which is also found in prenyl 
transferases (373). This shared motif between prenyl transferases and prenyl synthetases may 
indicate redundancy in function of the enzymes in bacteria. Therefore, it is plausible that in 
addition to metabolic prenylation, protein prenylation contributes to the pleotropic effects 
resulting from ablation of this modification. 
 
Future directions. Further investigations into the regulation and enzymatic activity of PrsS 
would better establish a role for this protease in mediating σS activity. Since promoter 
architecture analyses revealed a large intergenic region upstream of prsS, and transcriptional 
levels of the enzyme were discovered to be low under standard conditions, it is probable that 
negative regulators are mediating expression of the protease. In order to determine factors that 
repress transcription of the protease, a transposon library could be generated by inducing the 
random insertion of the bursa aurealis transposon (374, 375) in a prsS-lacZ reporter fusion 
strain. Screening the library for potential regulators would require isolating colonies with 
increased prsS transcription, evident by an increase in blue coloration, as under standard 
conditions the strain displays very low levels of blue pigmentation.  In order to determine the 
gene affected by transposon insertion, genomic DNA would be isolated, and sent for Sanger 
sequencing using transposon specific primers. In order to determine if these regulators directly 
bind the prsS promoter region, electrophoretic mobility shift assays (EMSAs) could be 
performed. To achieve this, putative regulators would first be purified and incubated with 
biotinylated prsS promoter region. This reaction would then be run on a native gel, and 
visualized using streptavidin substrates from a Pierce LightShift Chemiluminescent EMSA kit to 
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determine a difference in shift of DNA compared to control samples. A shift in DNA would 
indicate that the protein of interest is a direct regulator of prsS. 
 
In order to better understand the direct role of PrsS in σS activation, it is necessary to determine 
the identity of the anti-sigma factor. This could be performed by performing protein pull-down 
assays. Specifically, PrsS protein containing a his6-tag and mutations of its active site residues 
(E215A, E216A), could be purified and incubated with whole cell lysates in order to capture 
binding partners. Proteins that bind his6-tagged PrsS could be captured using HisPur cobalt 
agarose resin, and analyzed by LC-MS/MS to determine their identity. Subsequent to this, these 
identified proteins could be generated with a C-terminal-his6 tag, and expressed in S. aureus 
wild-type or prsS mutant strains. Cells would then be grown under standard conditions or DNA 
damage or cell envelope stress. Then, proteins would be harvested and separated by SDS-PAGE. 
Following this, western blot analysis would be used to visualize any size differences of the 
putative anti-sigma factor between the wild-type and mutant strains. If any one of the putative 
his6-tagged anti-sigma factors is cleaved, this would provide support for the protein as a substrate 
of PrsS. However, to in order to determine if the protein is an anti-sigma factor, interactions 
between the candidate and σS would need to be established by performing pull-down assays. 
 
In addition to purifying PrsS in order to determine the identity of interacting proteins and/or an 
anti-sigma factor, purified PrsS could also be subjected to biochemical assays in order to prove 
that it is a protease. This is of particular importance as the enzyme has been classified as a 
metalloprotease based on sequence homology to other proteases, but not direct experimental 
evidence. To this end, cleavage assays could be performed using a variety of substrates including 
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β-casein and synthetic peptides with homology to known anti-sigma factors, in order to 
determine if proteolysis occurs. In conjunction with this, metal ions would also be titrated into 
the reactions in order to determine if PrsS is a metalloprotease. 
 
In order to expand on the knowledge of the htrA proteases in S. aureus, it is necessary to 
demonstrate the enzymatic activity of the enzymes in order to provide evidence of proteolysis 
and/or chaperone abilities. To achieve this, the proteases would need to first be purified in native 
form. The purified enzymes could then be used in cleavage assays using a variety of substrates 
and temperature ranges in order to determine when the enzymes display activity. Similarly, the 
ability of the enzymes to fold damaged proteins could be tested by analyzing the ability to refold 
enhanced green fluorescent protein (EGFP) or citrate synthase, as these have been previously 
shown as in vitro substrates of E. coli HtrA (191). In order to achieve this, fluorescence of 
denatured EGFP incubated with purified HtrA would be monitored as a measure of chaperone 
activity of the enzyme, wherein fluorescence values are compared to native control EGFP 
samples. Similarly, the ability of the HtrAs to re-fold denatured citrate synthase could be 
measured by incubating HtrA1 or HtrA2 with the substrate, and sampling the reaction mixture 
over a time course for coenzyme A production, a product of citrate synthase. Coenzyme A 
production could be measured using a Coenzyme A Assay Kit (Sigma-Aldrich), in which 
production of the substrate can be quantified by fluorescence. As a negative control for both 
experiments, the re-folding capabilities of HtrA1 or HtrA2 containing mutations of active site 
residues (S255A for HtrA1 and S619A for HtrA2) will also be analyzed, as these variants should 
not exhibit chaperone abilities. Collectively, these assays that measure substrate proteolysis or 
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re-folding, could demonstrate whether HtrA1 and HtrA2 function as both proteases and 
chaperones. 
 
Additionally, the verification of interactions of the HtrA proteases with proteins identified in the 
Y2H screen could be accomplished by protein pull-down assays or analysis of degradation 
patterns for the putative substrates. In order to perform protein pull-down assays, HtrA1 or 
HtrA2 containing his6-tags and mutations of active site residues (S255A for HtrA1 and S619A 
for HtrA2) could be purified alongside putative interactors, which would contain a protein fusion 
with a different tag (MBP). The purified interactors would be incubated with HtrA1 or HtrA2, 
run on a native gel, and analyzed by western blot analysis to reveal if the proteins run at a 
combined molecular weight of the two proteins, indicating interaction. In efforts to analyze the 
possible proteolysis of the interacting proteins found in the Y2H screen, his6-tagged putative 
interactors would be expressed in S. aureus wild-type or htrA1 htrA2 mutant strains under stress 
inducing conditions to determine if degradation occurs.  
 
In efforts to further investigate the role of prenylation as a PTM in prokaryotes, future work 
would focus on the identification of prenylated proteins in S. aureus. One way prenylated 
substrates could be identified is by labelling and non-labelling proteomic approaches. 
Specifically, isotope-coded affinity tag (ICAT)-labelling proteomic analyses could be used in 
order to analyze difference in cysteine residue modifications (376), which may occur as a result 
of the attachment of prenyl groups, between wild-type and mutant strains. In order to achieve 
this, cytoplasmic, membrane, and secreted proteins would be extracted from wild-type and ispA 
mutant cells, and labelled with either a light or heavy acid-cleavable ICAT reagent. Subsequent 
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to this, differences in cysteine residue modifications among light and heavy-labelled peptides 
would be analyzed by LC-MS/MS. In addition to this method, a non-labelled proteomic 
approach could be performed in order to analyze the differences in membrane proteins among 
wild-type and ispA mutant strains. Although this is a less specific approach, the advantages to 
this method would be the ability to identify putative prenylated proteins, which are not modified 
at cysteine residues. This technique would instead rely on the idea that prenylated proteins are 
more hydrophobic, and characteristically membrane-associated. 
 
A targeted approach could be used to investigate the possible prenylation of the two proteins 
identified in the bioinformatic screen with C-terminal “CAAX” motifs. This could be 
accomplished by using a cell-free system that was previously developed to study prenylation in 
B. subtilis (254). Specifically, purified TrmE or SAUSA300_1902 would be incubated with 
either purified IspA or IspB (enzymes with potential transferase activity), and geranyl 
pyrophosphate or farnesyl pyrophosphate (prenyl groups) in order to allow for a protein 
prenylation to occur. The resulting products from this reaction would then be compared to 
synthetically prenylated peptides by LC-MS/MS in order to determine if in vitro prenylation of 
TrmE or SAUSA300_1902 occurs. 
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